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Infertility is defined as the inability of couples to achieve a clinical pregnancy within 
12 months of regular unprotected intercourse (1). The inability of conceiving 
a child has a strong impact on couples, including societal repercussions and 
personal suffering (2). The prevalence of infertility varies across different regions, 
on average about 15% of the reproductive-aged couples are affected by infertility 
(1). Infertility is related to male factors, female factors (i.e. factors affecting or 
interfering with ovulation, fertilization or implantation), a combination of these 
or the cause of infertility remains unclear. Male factor infertility contributes to 
approximately 50% of all infertility couples and affects 8-12% of men in Europe (3) 
and can be related to spermatogenesis or fertilization problems.
Spermatogenesis and fertilization
Spermatogonia develop into spermatozoa during spermatogenesis, which is a 
complex process that takes place within the seminiferous epithelium in the testis. 
This structure consists of germ cells and radially-oriented supporting somatic cells 
called Sertoli cells. An overview of the anatomical units involved in spermatogenesis 
and the three major phases (i.e. spermacytogenesis, meiosis and spermiogenesis) 
is shown in Figure 1.
Spermatogonial stem cells are located near the basement membrane of the 
seminiferous epithelium and divide either in type A spermatogonia, to renew 
stem cell population, or in type B spermatogonia. Type B spermatogonia are 
concomitant to the spermatogenic differentiation pathway. Afterwards, these 
cells entry into meiosis, where each cell will be divided into four round haploid 
spermatids (4). During spermiogenesis, a round spermatid will develop into a highly 
specialized spermatozoon. This transformation includes five steps: formation of 
the acrosome, nuclear changes, development of the flagellum, reorganization of 
the cytoplasm and cell organelles, and the process of release from the Sertoli cell 
termed spermiation (5).
The sperm cells produced in the seminiferous epithelia are transported through the 
rete testis and stored in the tail of the epididymis. During storage in the epididymis, 
maturation of the spermatozoa takes place, which is needed for spermatozoa to 
be capable of motility. Many morphological and structural changes occur during 
maturation, one of them is the formation of disulfide bonds between protamines 
for further DNA condensation (6). Once ejaculation takes place, the motility of 
spermatozoa becomes activated and they are transported through the vas deferens, 
where they are mixed with secretion from the prostate. Thereafter, fluid from seminal 
vesicals and secretions from the bulbourethral glands are added (7). An overview of 
the male reproductive tract is shown in Figure 2. The total process of spermatogenesis 
including transport in the ductal system takes approximately 3 months.
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Spermatogenesis is regulated by a complex integrated hormonal axis, known 
as the hypothalamic-pituitary-gonadal axis (see Figure 1). It all starts at the 
hypothalamus, where neurosecretory cells release gonadotropin-releasing 
hormone (GnRH). GnRH stimulates gonadotropin secretion by the pituitary 
gland, such as Luteinizing Hormone (LH) and Follicle-Stimulating Hormone 
(FSH) (8). LH stimulates the testicular production of testosterone in the Leydig 
cells. Testosterone and FSH are crucial to the initiation and maintenance of 
spermatogenesis and they are necessary for maximal spermatogenic output 
(5). Circulating testosterone regulates the production and release of LH by the 
pituitary gland via a negative feedback mechanism. FSH stimulates the production 
of inhibins by the Sertoli cells, which results in negative feedback on the pituitary 
production of FSH secretion (9). 
Spermatozoa enter during coitus the female genital tract in the anterior vagina, 
from where they swim quickly into the cervical canal. There they face the cervical 
mucus, which will become highly hydrated under the influence of estrogen to 
allow penetration of morphologically normal, motile sperm. After passage of the 
cervical mucus barrier, sperm are transported through the uterus. Transport is 
likely aided by contractile activity of the myometrium of the uterus. When sperm 
are subsequently transported through the uterotubal junction, they enter the tubal 
isthmus. The isthmus serves as a reservoir, where fertility of sperm is maintained 
until ovulation. At the time of ovulation, ovulatory factors like progesterone, induce 
sperm capacitation. Capacitation leads to sperm hyperactivation and prepares the 
sperm membrane to undergo the acrosome reaction by release of cholesterol from 
the sperm membrane. The hyperactivated sperm is released from the isthmus and 
will move through the Fallopian tubes, towards the oviductal ampulla (10). 
The spermatozoa that reach the ovulated oocyte in the ampulla, surround it and 
try to force through the cumulus mass. When a spermatozoon reaches the zona 
pellucida, binding with a glycoprotein sperm receptor (zona pellucida protein 3) 
takes place. This allows the spermatozoon to undergo the acrosome reaction and to 
successful penetration of the zona pellucida, whereafter the cell membranes of the 
spermatozoon and oocyte fuse. Factors from the post-acrosomal region activate the 
oocyte, leading to the release of cortical granules. Membrane fusion immediately 
causes the zona to become impenetrable for other spermatozoa and the oocyte 
to resume meiosis, leading to the extrusion of a second polar body (7). Thus, of the 
millions of sperm inseminated at the female genital tract, only a few thousand arrive 
at the Fallopian tubes and only one will fertilize an oocyte. Two pronuclei are formed 
and brought together in the center of the oocyte by the action of sperm centrioles, 
which results in syngamy and the first mitotic division (11).
12
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Figure 1. Overview of hypothalamic-pituitary-gonadal axis and the major phases of spermatogenesis
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Figure 2. Anatomy of the male reproductive tract (32) 
Causes of male infertility
Any defect in the complex process of spermatogenesis and fertilization can 
result in infertility. Disorders affecting the production of spermatozoa can mainly 
be divided in pretesticular, testicular and post-testicular causes of male factor 
infertility. In pretesticular dysfunction, the spermatogenesis is disturbed due to 
disorders of the hypothalamic-pituitary-gonadal axis. These endocrine disorders 
(i.e. disturbance of GnRH secretion, LH and FSH function or androgen function) 
have been identified in up to 20% of infertile men (12).
Testicular dysfunction is the most frequent cause of disturbed spermatogenesis 
and includes varicocele, genetics, cryptorchidism and exposure to gonadotoxins. 
Varicoceles are vascular abnormalities of the venous system of the testes. They 
are found in approximately 35% of men with primary infertility problems, but 
the exact mechanism of varicoceles causing infertility is still unknown. Moreover, 
in most cases it is unclear whether the varicoceles are actually the cause of the 
infertility. Cryptorchidism is abnormal descending of one or both testes before 
birth and is the most common congenital abnormality of male genitalia (13). 
Genetic disorders (such as deletions in the AZF region of the Y chromosome or 
Klinefelter syndrome) affect male infertility in various degrees, causing altered 
spermatogenesis, oligozoospermia, impaired normal development of the 
genital tract or decreased sperm motility and fertilization capacity. Examples 
of gonadotoxins and environmental factors affecting testicular functioning are 
14
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drugs, chemicals and excessive alcohol intake (12). Moreover, overexposure to 
other environmental factors may cause male infertility, such as heat and radiation.
Post-testicular deficiency includes ejaculatory dysfunction and obstruction of the 
excretory ductal system of sperm. Obstruction can occur along the epididymis, vas 
deferens or ejaculatory ducts. The most common cause of post-testicular infertility 
is epididymal obstruction, for example caused by previous infection or surgery. 
Moreover, vas deferens obstruction may be caused by an infection, vasectomy or 
hernia surgery (3). Ejaculatory dysfunction can be caused by neurologic, anatomic 
and psychologic conditions (for example diabetes mellitus and spinal cord injury) 
and can result in lack of emission ejaculation and retrograde ejaculation (12). 
Standard semen analysis
Semen analysis is performed to evaluate male fertility. The complex processes of 
spermatogenesis and fertilization are described earlier, but female factors also 
influence the fertilization potential. This reflects the difficulties of developing a 
test that reports the direct correlation between semen quality and the chance 
that a spermatozoon fertilizes an oocyte. Abnormal values in semen analyses are, 
therefore, an indication for abnormal spermatogenesis or inadequate transport 
of semen and is not a direct measurement of male fertility. 
The three main aspects assessed during standard semen analysis are sperm 
concentration, morphology and motility. Sperm concentration is defined as the 
number of spermatozoa per mL of semen. It is influenced by the volume of 
secretions produced by the prostate, seminal vesicles and bulbourethral glands, 
where spermatozoa are mixed with during ejaculation. Sperm concentration 
is, therefore, not a specific measure of testicular function, but it does relate 
to fertilization and pregnancy rates (14). The lower reference limit for sperm 
concentration is 15 million spermatozoa per mL, measurements below this level 
are defined as oligozoospermia (14). The lower reference limit for the total sperm 
number lies at 39 million spermatozoa per ejaculate, which in fact is a better 
measure of testicular function (15). 
The morphology of a spermatozoon is considered as normal, when head, midpiece 
and tail have a normal shape according to defined criteria (Table 1). The head plays 
an important role in fertilization, the midpiece generates energy for swimming and 
the tail plays an important role in the propulsion system of the spermatozoon (7). 
In this way, the percentage of morphologically normal spermatozoa is a predictor 
for fertility. The strict criteria for sperm morphology was introduced in the late 
1980s (16). A percentage of morphologically normal spermatozoa below 4% is 
considered as low (defined as teratozoospermia) (14).
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Table 1. Criteria for spermatozoa to be considered as normal
Head Midpiece Tail
• Smooth, regularly countered
• Oval in shape
• Well-defined acrosomal region  
40-70% of the head area
• No large vacuoles in acrosomal 
region
•  ≤2 small vacuoles in acrosomal 
region <20% of sperm head
• No vacuoles in post-acrosomal 
region
• Slender, regular and 
approximately the same length 
as sperm head
• Major axis aligned with major 
axis of sperm head
• Excess residual cytoplasm (i.e. 
when it exceeds 1/3 of sperm 
headsize)
• Uniform caliber along its 
length
• Thinner than midpiece
• Approximately 45 µm long 
(about 10 times head length)
• No sharp angle indicative of 
a flagellar break
The motility of spermatozoa is graded based on their level of movement: 
spermatozoa moving actively are progressively motile, motile spermatozoa with 
absence of progression are non-progressively motile and spermatozoa with 
no movement are immotile. Earlier, progressively motile spermatozoa were 
also categorized as being rapid or slow (WHO 1999). Motility of spermatozoa is 
needed to move through the female genital tract in order to fertilize the oocyte. 
The lower reference limits are 32% of sperm with progressive motility and 40% 
for total motility (both progressively and non-progressively motile spermatozoa), 
measurements below these levels are defined as asthenozoospermia (14).
In addition to these three main aspects, assessment of pH (>7.5), volume (> 1.5 ml), 
viscosity and other factors (for example round cells, bacteria, color) is performed 
during semen analysis. 
Classification
Semen analysis is an important requisite to evaluate male fertility. During 
anamnesis other factors should be taken into account as well, such as the duration 
of infertility, age of the couple and sexual, family, childhood, developmental, 
surgical and fertility history, and the possible exposure to gonadotoxins (17). 
Additionally, physical examination of the male and identification of possible 
genetic and endocrinologic factors may be determined. 
The World Health Organization (WHO) defines male factor infertility as the 
presence of at least one abnormal level of the three main aspects assessed during 
semen analysis (i.e. sperm concentration, morphology or motility) or inadequate 
sexual or ejaculatory function (18). The most significant abnormalities of semen 
analysis are oligozoospermia, teratozoospermia and asthenozoospermia, or a 
combination of these. About 15% of infertile men are diagnosed with azoospermia, 
which is the complete absence of sperm in the semen. Azoospermia is categorized 
as obstructive azoospermia, where the genital tract is apparently obstructed since 
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endocrine and exocrine systems show no abnormalities, and non-obstructive 
azoospermia, where spermatogenesis is abnormal while serological levels of FSH 
and LH are elevated (19). The most common abnormalities of semen analysis are 
related to non-obstructive infertility.
Classification can be based on the reference values of the WHO (see section 
standard semen analysis), but other reference values are described as well. It is, 
for example, suggested to classify sperm parameters based on their value into 
more clinically relevant categories (i.e. normal, borderline and pathological (20), 
or infertile, indeterminate fertile and fertile (21)). Furthermore, classification 
is dependent on the clinical interpretation of the results (e.g. focusing on the 
healthiness of the spermatogenic process or on the probability of becoming 
pregnant). Taking female factors into account, classification of male factor infertility 
is relevant for selecting the treatment option for the infertile couple. The three 
main treatment options for infertility are intrauterine insemination (IUI), in-vitro 
fertilization (IVF) and intracytoplasmic sperm injection (ICSI). During IVF, oocytes 
are collected and in-vitro fertilized by sperm. During ICSI, a single spermatozoon 
is injected directly into an oocytes cytoplasm. After fertilization, the embryo(s) are 
transferred into the uterus. 
IUI was initially used as treatment option for couples with mild to moderate 
male factor infertility, but is nowadays also offered to couples with unexplained 
infertility (22). Originally, IVF was introduced as treatment option for couples 
suffering from tuba pathology. Over the years, however, it was offered to couples 
with all kind of indications, including severe male factor infertility (23). ICSI 
was introduced to treat couples with severe male factor infertility or even with 
azoospermia (i.e. using testicular sperm extraction) (24). Selecting the correct 
treatment option for infertile couples is of importance for optimizing pregnancy 
rates and, consequently, minimizing the number of required treatment cycles. The 
selection of either IUI, IVF or ICSI, depends on tubal patency and the pre-wash total 
progressively motile sperm count (TPMSC). For example, when TPMSC is below 
a certain level the choice of treatment shifts from IUI towards IVF or ICSI. The 
three main aspects of semen analysis (i.e. sperm concentration, morphology and 
motility) are assessed not only to evaluate testicular function, but also for selecting 
the best treatment option. It is, therefore, of importance that assessment of these 
factors is as adequate as possible. 
Intrauterine insemination
Of all artificial reproductive technologies, IUI is one of the first treatment options for 
couples suffering from infertility and is the most simple and less invasive method. 
During IUI, washed and concentrated sperm are inserted through the cervical canal, 
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directly into the uterus, around the time of ovulation. The goal of IUI is to increase 
the number of sperm reaching the fallopian tube and, subsequently, increasing 
the chance of a sperm cell to fertilize an oocyte. To improve the chance of getting 
pregnant, IUI can also be carried out in combination with ovarian stimulation. 
Ovarian stimulation increases the number of oocytes available for fertilization 
(25). Although this increases the chance of getting pregnant, it also increases the 
chance of a multiple pregnancy (26). Multiple pregnancies cause more maternal and 
perinatal mortalities and morbidities compared to singleton pregnancies.  
IUI is a less invasive and less expensive treatment option compared to IVF and 
ICSI. In couples with mild to moderate male factor infertility (e.g. ≥1 million motile 
spermatozoa), IUI is recommended as first-line therapy in many clinics (27). The 
rationale for this is that during the washing process of the semen sample, sperm 
with the best morphology and motility are concentrated and prepared for injection 
in the uterus. If IUI is offered to couples with mild to moderate infertility, clinical 
pregnancy rates range between 10-20% per cycle. Moreover, IUI is a cost-effective 
therapy in selected couples with mild male infertility, but also couples with cervical 
factor and immunological infertility (28). IUI is also an effective therapy in couples with 
unexplained infertility. Even though the exact difference in pregnancy rates is unclear, 
clinical studies showed that a combination of mild ovarian stimulation with IUI results 
in a higher chance of pregnancy in couples with unexplained infertility (29).
Shortcomings of semen analysis and IUI
Semen analysis has been performed for many years, as part of the diagnostic 
trajectory and for selecting the treatment option offered to an individual 
couple. However, semen analysis is characterized by a lack of standardized 
methodologies. This lack of standardization applies also to the different sperm 
preparation techniques used for assisted reproductive technologies (30, 31). The 
willingness to follow guideline recommendations was limited and a majority of 
fertility centers still use their own materials and methods (32). Moreover, provided 
recommendations were incomplete, due to a lack of supporting evidence (32). In 
order to realize standardization, more knowledge concerning semen analysis and 
IUI methods and their impact on pregnancy rates is necessary. 
Another pitfall of semen analysis is the risk of subjectivity of the measurement, 
which can lead to variability of the results (i.e. intra- and inter-observer and 
inter-laboratory variability) (33). Strategies to overcome these problems related 
to semen analysis include training of the technicians performing semen analysis 
and the introduction of external quality control programs. Training including all 
different aspects of semen analysis resulted in a reduction of the variability (34), 
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but also in awareness of the need of standardization among the participating 
technicians (35,36). Quality control is a requisite to measure precision and accuracy 
of semen analysis results, which indirectly results in a lower level of variability of 
the three main aspects of semen analysis (i.e. sperm concentration, morphology 
and motility) (37) and improves standardization of the used methods (38). 
Next to these technical shortcomings, another ongoing debate related to semen 
analysis is the value of sperm parameters as predictors of IUI outcome (31,39). The 
influence of sperm morphology assessment shows conflicting results on predicting 
pregnancy outcomes, especially since the introduction of ICSI. Since then, poor 
semen quality is usually a reason to select ICSI as treatment option, irrespective 
of sperm morphology (except for rare cases, such as globozoospermia). There 
is also disagreement on the predictive value of the total progressively motile 
sperm count (40) in IUI. These studies, however, were characterized by a lack of 
standardization. 
The selection procedure in order to select the offered fertility treatment (i.e. IUI, IVF 
or ICS) has also been subject of discussion (41). Earlier research showed insufficient 
evidence to select one treatment option over the other, especially in couples with 
male factor infertility (42). Due to imprecise and inconsistent study designs, it was 
even not possible to report any differences in safety or effectiveness of fertility 
treatments (including timed intercourse, IUI, IVF and ICSI) (42). For these reasons, 
the British National Institute for Health and Care Excellence NICE) reduced the 
indications for IUI to sexual dysfunction, same sex relationship and selected 
conditions (43). Evidence for this recommendation, however, was reported as not 
sufficiently robust (44). However, others showed that IUI favors over IVF in many 
couples, based on clinical and economical evidence (45).
Despite these shortcomings, semen analysis and IUI are performed on a large 
scale, and conducted in many fertility clinics around the world (46,47). It is, 
therefore, important to improve the accuracy of semen analysis and the pregnancy 
outcomes of IUI. This will eventually result in improved counseling of infertile 
couples resulting in selecting the best treatment option for the couple.
Outline
Semen analysis and IUI are important requisites in the diagnosis and treatment of 
infertile couples. A lot of further research is needed for the optimization of semen 
analysis and IUI. This will eventually result in better counseling and treatment of 
infertile couples. The overall research question studied in this thesis is therefore: 
what tools and recommendations should be provided to infertility clinics as best 
practice for semen analysis and IUI in couples with male factor infertility? Answers 
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to this research question are described in chapters 2 -6. Their main goals are 
described below.
The importance of standardization in semen analysis and IUI protocols has been 
emphasized before (27). Since a lack of standardization might result in distinct 
selection of treatment option offered to the infertile couple, it might result in 
inter-laboratory variation in pregnancy rates (38). Chapter 2 provides, a literature 
overview of the association between pregnancy results of IUI and procedures 
used during the technical stage between semen collection and insemination. The 
provided recommendations aim to define best practice to realize standardization 
and can be a starting point for further research. To evaluate the implementation 
of the procedures recommended in chapter 2, chapter 3 describes Dutch actual 
care by summarizing the used procedures of IUI and semen analysis in Dutch 
fertility laboratories, as well as their effect on pregnancy results.
Next to optimizing IUI procedures, correct counseling of infertile couples and 
selection of the best treatment option for the individual couple is important. 
These steps are, among others, based on standard semen analysis results. It is, 
therefore, important that the predictive value of semen parameters for IUI success 
is investigated (28). This was studied in Chapter 4, where the value of sperm 
morphology and progressively motile sperm count to predict IUI pregnancy results 
is presented. In order to improve the relevance of semen analysis results, intra- 
and inter-observer variability and inter-laboratory variability should be reduced 
(39). Strategies to reduce variability in semen analysis results are introduction 
of external quality control programs (40) and training of technicians performing 
semen analysis (41). The impact of external quality control and standardized 
training in the Netherlands on semen analysis results is described in Chapter 5. 
Furthermore, an overview of the impact of a short on-site training on the semen 
analysis results in the Dutch EQC program is shown in Chapter 6. 
This thesis concludes in Chapter 7 with a review of the main findings and a general 
discussion on these findings. Furthermore, recommendations for clinical practice 
and future research are provided.
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Study question: Are the guidelines for the technical aspects of IUI (WHO, 2010) still 
in accordance with the current literature?
Summary answer: In general, the laboratory guidelines of the World Health 
Organization (WHO) are a suitable protocol, although the evidence is not always 
conclusive and some changes are advisable.
What is known already: Lack of standardization of the technical procedures 
required for IUI might result in inter-laboratory variation in pregnancy rates. Most 
centers still use their own materials and methods even though some guidelines 
are available.
Study design, size, duration: A structural review focusing on the association 
between pregnancy rates and the procedures of semen collection (e.g. ejaculatory 
abstinence, collection place), semen processing (e.g. preparation method, 
temperature during centrifugation/storage), insemination (e.g. timing of IUI, bed 
rest after IUI) and the equipment used.
Participants/materials, setting, methods: A literature search was performed 
in Medline and the Cochrane library. When no adequate studies of the impact 
of a parameter on pregnancy results were found, its association with sperm 
parameters was reviewed.
Main results and the role of chance: For most variables, the literature review 
revealed a low level of evidence, a limited number of studies and/or an inadequate 
outcome measure. Moreover, the comparison of procedures (i.e. semen 
preparation technique, time interval between semen, collection, processing and 
IUI) revealed no consensus about their results. It was not possible to develop an 
evidence-based, optimal IUI treatment protocol.
Limitations, reasons for caution: The included studies exhibited a lack of 
standardization in inclusion criteria and methods used.
Wider implications of the findings: This review emphasizes the need for more 
knowledge about and standardization of assisted reproduction technologies. Our 
literature search indicates that some of the recommendations in the laboratory 
guidelines could be adapted to improve standardization, comfort, quality control 
and to cut costs.
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Introduction
At the moment, there is an ongoing discussion about the value of IUI. Recent Dutch 
studies showed a positive performance of the treatment especially in cases of 
mild andrological and unexplained infertility (1,2,3). On the other hand, the British 
guideline for infertility treatment strongly reduced the indications for IUI to sexual 
dysfunction, same sex relationship and special conditions (4). In this guideline, 
clinics are directed to apply in IVF or ICSI as a first line treatment in the majority of 
cases. However, the evidence cited to support this guideline was, not robust (5). 
Not only clinical, but also economical and financial evidence favors IUI over IVF in 
many cases (6). A lot of discussion is ongoing on this subject (7-9). Probably, for this 
reason, until now only a small proportion of clinics have made significant changes 
to their IUI practice (10) and IUI is still performed on a large scale worldwide and it 
is remains worthwhile to try to improve the outcome.
The IUI procedure can roughly be separated in three steps: diagnosis and 
indication, cycle preparation and the technical stage. The third step, including the 
whole process between semen collection and insemination, is barely included in 
guidelines. Only the World Health Organization (WHO) laboratory manual (11) 
attempts to describe the process. This description is incomplete, because parts of 
the pre- and post-laboratory stages are missing.
This structural review focuses on the technical phase of IUI and we check whether 
the present guidelines are in concordance with available literature. As the WHO 
manual (11) is the only international guideline that describes a protocol for semen 
collection, analysis and preparation, we used this guideline as the main reference 
point for our study.
Methods
The available literature on the following procedures or variables of IUI was 
reviewed: ejaculatory abstinence (EA), semen collection place, time intervals (i.e. 
between semen collection and semen processing, between semen processing and 
insemination, and between semen collection and insemination), semen preparation 
methods, centrifugation medium, centrifugation and storage temperature, timing 
of IUI, use of different disposables (e.g. catheters) and duration of bed rest after IUI.
A computerized search was carried out in Medline and in the Cochrane library. Key 
words for the search were ‘intrauterine insemination’, ‘IUI’ or ‘artificial insemination’. 
Specific key words used for the individual variables included: ‘ejaculatory 
abstinence’, ‘ejaculatory frequency’, ‘time interval’, ‘collection to processing’, 
‘collection to IUI’, ‘processing to IUI’, ‘semen purification’, ‘semen preparation’, 
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‘semen separation’, ‘density gradient’, ‘swim up’, ‘wash’, ‘buffer’, ‘zwitterion’, 
‘bicarbonate’, ‘HEPES’, ‘MOPS’, ‘TEST’, ‘medium’, ‘temperature’, ‘centrifugation’, 
‘incubation’, ‘storage’, ‘timing’, ‘insemination timing’, ‘disposable’, ‘devices’, ‘tube’, 
‘glove’, ‘pipette’, ‘catheter’, ‘collection container’, ‘bed rest’, ‘supine positioning’, 
‘immobilization’ and ‘mobilization’. The titles and abstracts were screened to 
exclude citations considered as irrelevant, thereafter full texts of potentially 
eligible studies were reviewed. Articles published before 1 November 2016 in 
peer reviewed journals in the English language were included. The references and 
related citations of these articles were used to identify extra potential articles of 
interest. Studies reporting the impact of used laboratory procedures on sperm 
parameters or IUI pregnancy rates (PRs) were included.
The recommendations on technical aspects of IUI stated in the WHO guideline (11) 
were used as reference and compared with the results of the literature search. 
The results were arranged in an evidence-level structure as described by NICE (4). 
Finally, a summary is given of the recommendations, limitations of the available 
literature and knowledge gaps.
Ejaculatory abstinence
The WHO recommends an EA period of 2–7 days before semen collection (11), 
both for diagnostics and semen preparation. Although no explanatory literature is 
provided, studies on sperm parameters support this recommendation since an EA 
of 2–7 days resulted in a significantly higher semen volume (12-14) and total motile 
sperm count (TMSC) (15-17). On the contrary, a recent study reported a significant 
higher sperm motility for ejaculates of infertile men if they were produced within 
40 min after an initial sample with <5 million motile spermatozoa (18). Moreover, 
an EA period of 0–2 days also resulted in higher percentages of morphologically 
normal spermatozoa (16,18,19).
The explanation of these observations can be found in the effect of reactive oxygen 
species (ROS). A certain level of ROS is required for the maturation of epididymal 
spermatozoa (20). Excessive ROS, however, can induce oxidative damage which 
negatively affects the fertilization potential of spermatozoa (14). The exposure time 
of spermatozoa to ROS is influenced in an EA time-dependent manner, thereby 
influencing the incidence of sperm DNA fragmentation, especially in infertile men 
(21,22). As a consequence, a shorter period of EA will result in higher PRs both in 
natural and IUI cycles, especially in sub-fertile men (23,24).
So far, the relationship between duration of EA and IUI PRs has been investigated 
in only two retrospective studies. These studies showed a negative impact 
of longer EA periods on PRs in cohorts of 372 (17) and 417 couples (15). These 
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studies reported highest PRs in the group with an EA up to 2 days and up to 3 
days, respectively. In a retrospective pilot study, it was also found that in cases of 
oligozoospermia, the aggregation of consecutive ejaculates resulted in a higher 
PR (25). So, irrespective of a higher TMSC, the WHO recommendation of 2–7 days 
is debatable. A possible bias in the plea for a shorter EA is that these couples had 
intercourse shortly before insemination, thereby increasing the probability of a 
natural conception. More studies are needed to confirm these findings, both in 
normozoospermic and oligozoospermic men. For now, it can be advised to change 
the WHO recommendation into an EA period of maximum 3 days.
Time intervals
The time intervals between semen collection to processing, processing to 
insemination and semen collection to insemination have impact on IUI PRs (Table 
I). However, the WHO provided only a recommendation for the time interval 
between collection and processing (11). They stated that semen sample collection 
for IUI should preferably take place in a private room near the clinical laboratory, 
but when collection at home is preferred the semen should be delivered to 
the laboratory within 1 h after collection (while protected from extremes of 
temperature) (11).
When comparing PRs, a higher PR was reported when semen was collected in 
the clinic (26). Another study found no difference in PRs between collection at 
home and in the clinic (27). Furthermore, semen collection in the clinic led to a 
time interval that was on average 26 min shorter than collection at home (26). 
Nevertheless, no impact of time interval duration was found in a large study 
population (n = 633 cycles) (27). This was also shown in women treated with 
clomiphene citrate (n = 95 cycles) in another study (26). On the contrary, a shorter 
time interval (i.e. 15–30 min) resulted in a higher PR in a small group of women 
treated with human menopausal hormone (hMG; n = 37 cycles) (26). Lower PRs 
caused by longer time intervals, might be explained by decapacitating factors in 
the seminal plasma (28-30) or ROS-induced DNA damage (14,26).
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Table I. Summary of findings reported by literature when comparing the impacts of time intervals on 
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*results reported in couples with human menopausal gonadotropin (hMG)-treated women, no differences 
in couples with clomiphene citrate (CC)-treated women    
- = not available in study
Regarding storage time after processing (i.e. time interval between processing 
and insemination), a shorter time interval was related to a lower proportion of 
premature sperm chromatin decondensation (31), to less sperm DNA fragmentation 
(32) and to a higher PR due to the storage time-dependent spontaneous acrosome 
reaction (32,33). In practice, however, no consensus was shown in reported ideal 
time intervals. PRs were comparable when IUI was performed within 30 min or 
after 31–60 min of storage, but decreased after >60 min, only in couples with 
hMG-treated women (26). Others reported highest clinical PRs in the groups 
with a storage time of 40–80 min (32) and >30 min (34). With another approach, 
another study (27), found no differences in in storage time intervals between a 
group of pregnant and non pregnant couples. Moreover, a recent study reported 
no difference in ongoing PRs between immediate insemination and insemination 
one day after semen processing (35).
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Two retrospective studies evaluated the impact of the total time interval between 
semen collection and insemination. In one study, higher PRs were found when 
insemination took place within 90 min after semen collection (i.e. compared to 
91–120 min and >120 min) (26), the other study found no differences (27).
In conclusion, literature on this subject is scarce and presented contradictory 
results. More information can be obtained in RCTs, but also in retrospective, 
well-designed multicenter studies, where standardized time intervals should be 
compared. For now, it is not possible to recommend one time interval over the 
other, nevertheless, the majority of the results propose to avoid long time intervals. 
Especially the time interval between semen collection and processing should not 
exceed 60 min, since no pregnancies were reported in this group (26,27).
Semen preparation methods
After semen production and liquefaction, it is necessary to separate sperm from 
the seminal plasma, thereby preventing uterine cramps, extended ROS formation 
and inhibition of fertilization (28,36). Many separation techniques have been 
described. Compared to the initial semen sample, the use of all these techniques 
resulted in significantly better semen parameters (37-39) and higher IUI PRs (40).
According to the WHO, the choice of semen preparation technique should be 
based on the nature of the semen sample (11). It is recommended to use swim-up 
in cases of normozoospermia, while density gradients should be the method of 
choice in other cases.
Density gradient centrifugation started with the use of PercollR. In 1996, however, 
PercollR was withdrawn from the clinical market, since it was stated that the 
polyvinylpyrrolidone (PVP)-coated silica in PercollR contained endotoxins (41). 
Since then, several endotoxin-free products with silane-coated silica particles 
were introduced. In first instance, research concentrated on comparing these 
new products to PercollR and conflicting results were found with respect to sperm 
motility and recovery rate (38,42-47). Despite these disagreements, silane-coated 
products are now widely used (48).
There is consensus that the swim-up technique resulted in lower recovery 
rates compared to density gradient centrifugation, making it suitable only in 
cases of normozoospermia (48,49). As swim-up selects spermatozoa based on 
their motility, one would expect that it would result in a high fraction of motile 
spermatozoa. Some studies, however, reported a comparable or even lower 
motility if swim-up was compared to gradients (50-52). The same is true for the 
percentage morphologically normal spermatozoa (50,53-55).
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In practice, the clinical outcome of IUI is of more importance than the value of 
semen parameters. In 2007, a systematic Cochrane review (56) included six RCTs 
in their meta-analysis, comparing the effectiveness of density gradient techniques 
versus swim-up techniques and versus wash-only. They concluded that there is 
no evidence to choose for one technique over the other. The included studies, 
however, were characterized by low numbers of patients, diversity in the cause 
of infertility and diversity in the techniques that were compared. Only one study 
(57) included a larger study population (n = 363). Still, this study is of limited value, 
since five different techniques were studied in a population with all causes of 
infertility. Since Boomsma’s review, only one suitable RCT has been performed. 
A significantly higher PR (both per cycle and per couple) was found using density 
gradient centrifugation (SpermGradR) compared to the swim-up technique, in 
couples with unexplained infertility (58). An overview of all studies is given in Table 
II (47,52,58-64). Additional studies with standardized patient inclusion criteria and 
study designs are necessary to confirm the results obtained from these studies. 
pH buffer of washing and storage medium
To maintain an optimal pH level, the WHO recommends to select a buffer medium 
based on the used incubator: a zwitterion-buffered medium (e.g. HEPES, TEST, 
MOPS) if the incubator contains atmospheric air and a bicarbonate-based medium 
if the incubator contains an atmosphere of 5% CO2 (and if gas exchange is 
allowed) (11). Meanwhile, most commercially available sperm wash media contain 
zwitterions for pH buffering, although a certain level of bicarbonate is present as 
key capacitating agent for spermatozoa (65). Although these media are effective, 
there are concerns that zwitterion buffers may interfere with some important 
processes in different cell types and, consequently, have negative effects on 
gametes and embryos (66).
As far as we know, only one RCT (67) compared the PRs of sperm prepared with 
bicarbonate buffer and with HEPES buffer, in IUI with cryopreserved donor sperm 
(n = 324 cycles). This study reported significantly higher PRs when sperm was 
prepared using HEPES buffer. It has to be stated, however, that the effect might 
not be attributed to HEPES alone as two different culture media were used (HTF 
and HAM’s F10). More RCTs are necessary on this subject, with stratification for 
normozoospermic and oligozoospermic men, and with temperature as important 
factor as the pH of buffers is temperature-dependent.
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Temperature during centrifugation 
It was suggested that the impact of the centrifugation temperature on sperm 
capacitation might mimic the impact of the storage temperature (68), as reported 
later in this review. In a group of 50 normozoospermic men, however, no significant 
difference was found in the level of DNA damage between samples centrifuged 
at controlled (testis or body temperature: 35 or 37°C, respectively) and non-
controlled temperature (room temperature: ~25°C) (69). In another small group of 
normozoospermic men (n = 10), the percentage of motile sperm cells was higher 
after centrifugation at 34°C compared to centrifugation at room temperature (70). 
The samples centrifuged at 34°C were reported with a higher sperm yield, but only 
when they were also stored at this temperature before semen processing. Both 
studies provided no explanations for the temperature-dependent influences of 
semen centrifugation.
Only one RCT (n = 671) evaluated the impact of centrifugation temperature on IUI 
PRs. Included were couples with unexplained infertility and no differences were 
found in sperm parameters and IUI PRs between controlled and non-controlled 
centrifugation temperature (71). Based on this RCT and since non-controlled 
centrifugation is commonly used for reasons of ease, we conclude that further 
evaluation is not needed at this moment.
Temperature during storage 
Usually, the storage of semen samples after preparation takes place at body 
temperature. Long-term storage (≥24 h) of spermatozoa at body or testis 
temperature, however, resulted in reduced motility and sperm quality (72,73). 
In general, reduced motility is observed both at room and body temperature in 
a time-dependent manner, but to a greater extent and more rapid at 37°C (74). 
Moreover, long-term storage at 37°C resulted in an increased incidence of large 
vacuoles in sperm nuclei (75). The positive impact of lower storage temperatures 
is explained by the switch of spermatozoa to a resting state, where better energy 
preservation might result in longer survival (73). This hypothesis is supported 
by the reported influence of storage temperature on some cellular mechanisms 
involved in sperm capacitation: a temporary blockage of capacitation-related 
events was present during storage at 20°C, but not at 37°C (68).
Clinical studies about the impact of storage temperature on PRs are missing. 
Furthermore, the above studies included small groups of men (n = 12–41) and did 
not specify the impact separately for fertile and infertile men. Further research is 
needed to evaluate the impact of storage temperature on IUI PRs. As literature is 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The timing of insemination comprises two variables: the detection/induction 
of ovulation and the time interval from this point to insemination. The WHO 
guideline provides no recommendations for one timing method over the other. 
According to the NICE, however, the use of basal body temperature charts does 
not reliably predict ovulation (4). In 2014, a review (76) included 18 RCTs about 
the effectiveness of different timing methods in natural and stimulated IUI cycles. 
When comparing hCG administration and LH surge as timing method for IUI, no 
differences in PRs were found, albeit the quality of evidence was low or very low. 
Additionally, double inseminations (e.g. at 24 and 48 h after ovulation induction) 
and the use of different types and dosages of hCG and GnRH-a resulted in no 
differences in IUI PRs (76,77).
Next to ovulation timing method, the timing of insemination can be discussed. The 
NICE guideline stated that insemination should be performed around ovulation 
(4). In literature, the comparison of different time intervals between ovulation 
induction and insemination showed no statistically significant differences in PRs 
(78-84). The majority of these studies compared time intervals between 24 and 48 
h after ovulation induction. From a biological view, however, the insemination of 
sperm before ovulation might be favorable, i.e. at the time of ovulation induction 
(85,86). After intercourse, spermatozoa attach to the isthmus epithelium, where 
this binding keeps them viable and prevents capacitation (86). Moreover, this 
interaction results in de novo protein synthesis (87). Once ovulation occurs, 
a cascade of signals results in a hyperactivated sperm movement towards the 
oocyte (88). This ovulation-related timing mechanism is important, since an early 
start of capacitation resulted in apoptosis of the spermatozoa (89), while a late 
start of capacitation resulted in spermatozoa that were not equipped to recognize 
oocytes (88). Although the majority of these processes was found in animal 
studies with healthy subjects, it would be worthwhile to set up clinical studies 
to tests this theory in humans. Only one study compared PRs between injection 
simultaneously with administration and 34–36 h after hCG administration, but 
found no statistically significant differences (83).
Other treatment related factors might affect the correct moment of insemination. 
For example, embryos might be affected by premature luteinization, due to an 
early rise in progesterone at the end of the follicular phase in controlled ovarian 
hyperstimulated IUI cycles. This early rise of progesterone was observed in 22% of 
the cycles and led to reduced PRs from 23 to 8% (90). Also, human papillomavirus 
positivity was found to have a negative impact on IUI PRs (91).
Additional (multicenter) RCTs are recommended on all of these aspects.
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IUI devices
The most important devices of influence on IUI results are laboratory and clinical 
disposables and media, like semen containers, wash media and catheters. Two 
possible impacts of these products can be distinguished: function and toxicity. With 
respect to function, the type of catheter and ultrasound guidance can be of influence. 
A soft tip catheter was found to cause less trauma to the endometrium compared 
to a hard tip catheter (92), but was not superior in PRs in a Cochrane review (93). 
Ultrasound guidance during insemination makes it possible to visualize the movement 
of the catheter inside the endometrial cavity and could so avoid endometrial trauma 
and uterine contractions (94). This ultrasound guidance did not result in higher PRs 
in comparative studies (95-97), it will only result in more complexity and higher costs.
For both laboratory and clinical equipment, cytotoxicity is a problem. Nijs and 
colleagues (98) state that toxicity can be caused by the composition of materials, 
the production process, the handling and packaging or the sterilization and 
transport processes. Using a human sperm survival assay (HSSA), these authors 
demonstrated that one type of sterile Pasteur pipette was related to a delayed 
manifestation of toxicity and that the inside lid of one type of sperm container 
caused an immediate negative impact on sperm motility. Others reported toxicity 
of certain ART products by use of a mouse embryo assay (MEA). The set up and 
validation of both assays is however poorly described, both biologically (99) and 
statistically (100). Also, pre-release clinical safety and effectivity tests of devices is 
missing in many cases and European legislation is unclear on this point (101). We 
conclude that additional well-described tests are needed before introduction of 
IUI and ART devices on the market.
Bed rest after IUI 
The WHO guideline provides no recommendations for bed rest after IUI (11). 
The rationale for a positive impact of a short period of supine positioning after 
insemination is that the spermatozoa may reach the fallopian tube within only 10 min 
(102). Immediate mobilization might counteract this movement due to gravity (103).
Few RCTs evaluated the impact of 10–15 min of supine positioning on IUI PRs 
compared to direct mobilization. In two of these RCTs, with inclusion of 391 and 95 
couples, supine positioning led to higher PRs (104,105). In disagreement with these 
findings, a recent RCT found no significant positive effect of bed rest after IUI. This 
study was performed in 479 couples with idiopathic or mild male subfertility (106). 
Possible explanations for these differences might be found in the indications for 
IUI and the number of treatments. For this moment, it is not possible to advise one 




Table III gives a summary of the impact of different laboratory procedures on 
IUI success. Also, the corresponding levels of evidence (LOE) according to the 
NICE guideline (4) are shown. These LOEs are however more or less misleading, 
especially in the assignment of level 1a and 1b. In these cases, the included RCTs 
are most of the times characterized by the absence of standardized methods or 
small sample sizes, resulting in contradictive results. In general, it is remarkable 
that the procedures for IUI are characterized by a low level of evidence or 
insufficient literature even though IUI has been performed for decades. Even 
well-designed retrospective studies are missing, while these could be performed 
relatively simply and would lead to valuable information for efficiently setting up 
the more complex RCT's.
Discussion
The general conclusion of this review is that evidence is poor on most technical 
aspects of the IUI procedure. Different studies show contradictive results, mainly 
due to a low degree of standardization, low statistical power and inaccuracy in 
handling confounding factors. Nevertheless, some advise can be given to change 
the current guidelines.
We state that an EA period of up to 3 days is preferable to the 2–7 days described 
in the WHO manual. Furthermore, we advised avoiding long time intervals 
between semen production and processing. It is easier to perform centrifugation 
and storage at room temperature and this yields good results. Finally, zwitterion-
buffered media might be preferred over bicarbonate-buffered media and IUI 
devices should be validated using HSSA.
Although only a part of these recommendations are really evidence-based, we 
think that they could be introduced for reasons of standardization, comfort (ease), 
quality control and costs. This does not mean that further research on these 
items is expendable. As literature is scarce, every new study can influence the 
recommendations. This was also the case for two items in this review: the time 
between sperm preparation and insemination and bed rest after insemination. In 
these cases, a recent retrospective study and RCT, respectively, reported different 
study results than the former literature, which resulted in a last-minute change of 
the recommendations.
Although RCTs can be preferred, multicenter retrospective studies could be 
informative as well in some cases, because these studies can give us the possibility 
to include the many variables that are present in the IUI process over the different 
clinics. In these studies, it is important that the participating clinics share the same 
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definitions on their data, e.g. for cycle number, pregnancy outcome and underlying 
diagnosis. Furthermore, a good registration of all technical variables is important. 
Next to clinical studies, for some variables, it could also be useful to perform 
biological experiments as alternative, like zona binding assays or measurement 
of DNA damage after different time intervals of incubation of prepared semen.
Based on the results of this review and in agreement with other IUI-related reviews 
(56,107), we emphasize the importance of standardization in IUI (study) protocols 
and guidelines. Here we meet another problem, since the readiness of clinics to 
follow existing guidelines is low (108,109), even when two different implementation 
strategies were used (110). An overview of guideline adherence of the laboratory 
stage of IUI is missing. We assume that this will be low also, because (older) studies 
ascribe limited willingness to follow guideline recommendations for processes 
related to IUI, like semen analysis (107,108,111-113) and to the vagueness and 
incompleteness of the recommendations, since supporting evidence is missing 
(111,114). We agree with earlier statements (115) that efforts should be made to 
improve guideline development and implementation by means of clinical results 
and economic consequences of IUI care.
This review indicates that further research on many IUI-related factors is necessary. 
We suggest to start with evaluating the current adherence to laboratory guidelines, 
e.g. by sending a questionnaire to fertility laboratories. This is also relevant 
with respect to semen analysis, as highlighted before (6); only a fraction of the 
laboratories is ISO 15189 accredited to the WHO standards for semen analysis 
(11). This may lead to wrong classification of semen samples and therefore 
disproportionate use of IVF and ICSI treatments.
Next, further research to update the current recommendations should include 
RCTs focusing on the impact on IUI success of wash medium buffers, storage 
temperature, timing of insemination (<24 h after ovulation induction) and bed 
rest. A first multicenter RCT could focus on two aspects of the sperm preparation 
method: gradient centrifugation compared to swim-up and bicarbonate compared 
to HEPES buffer. This study can be performed with enough power within a limited 
period of time. Whether aspects like EA and collection place should be studied 
in RCTs is point of discussion. In these cases, multicenter retrospective studies 
including patient and treatment characteristics (e.g. female age, cycle number, 
ovarian stimulation protocol) can be helpful instead.
With the results of these studies, guidelines can be updated and implementation 
strategies (e.g. educational materials or standardized training visits) can be 
drawn up. Subsequently, the effectiveness of the implementation strategy can be 
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3CHAPTER 3Optimization of laboratory procedures for intrauterine insemination: survey of methods in relation to clinical outcome
L. Lemmens, S. Kos, C. Beijer, D.D.M. Braat, M.A.Jonker, W.L.D.M. Nelen,   
A.M.M. Wetzels




Background: There is a wide practice variation of used methods and outcomes 
in IUI in fertility laboratories. Standardization of the IUI procedure is important 
for reducing inconsistency among laboratories in counselling infertile couples 
and in pregnancy results. The aim of the study was to evaluate the currently 
used laboratory procedures of IUI in Dutch fertility laboratories and their effect 
on IUI pregnancy results. Additionally, the methods for semen analysis (SA) were 
evaluated, as SA is related to IUI in terms of inseminated sperm number and IUI 
counselling. 
Material and Methods: This questionnaire survey study was sent to laboratories 
participating in the Dutch external quality control program for semen analysis 
(SKML) and consisted of 46 questions concerning laboratory management, 
methods for semen analysis and IUI and clinical results. The results were analyzed 
using univariable and multivariable logistic regression models.
Results: A total of 52 laboratories (out of 99) provided information on used 
methodologies for SA or laboratory procedures of IUI and the organization of the 
laboratory. A wide variability was confirmed in used methods for both SA and IUI. 
Evaluation of pregnancy results obtained during 3 years (2013-2015) showed that 
specific used laboratory methods have a significant effect on the probability of 
becoming pregnant. 
Discussion and conclusion: Important to remark is that in this survey study 
cycle specific data, including variables of the individual couples (age, stimulation 
protocol, etc) were not included and may have effects on the results. The reported 
results provide an overview of the current practice performance, however, the 
organization of fertility laboratories is changing rapidly. The use of standardized 
methods in IUI is important for optimizing the performance of care and improving 
pregnancy results. The knowledge on used procedures, however, is limited and 
further research on factors involving SA and the IUI procedure is necessary.
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Introduction
Intrauterine insemination (IUI) is a commonly used procedure, conducted in many 
fertility clinics around the world (1,2). The results of the treatment are dependent 
on many factors, like female and male age, female factors, semen quality and 
treatment type (e.g. natural vs stimulated cycle, type of ovulation induction and 
timing of the insemination). The best indications for IUI are moderate male factor 
and unexplained infertility (3), with especially tubal factor infertility as contra-
indication. Moreover, mild ovarian stimulation generally leads to better results 
than natural cycle IUI, thereby having a higher risk for multiple pregnancies (4,5). 
With respect to the effect of semen factors on IUI, studies report contradictive 
conclusions. Many authors report a minimum required motile sperm count (TMC) 
for effective IUI, however there is no consensus about the exact value of this 
minimum (6). Next to this minimum TMC, a maximum is reported in two studies 
(5,7). Also the impact of sperm morphology for successful IUI is under discussion. 
Although some groups report a certain impact of sperm morphology on the results 
of IUI, in a recent review it was concluded that it has a very poor clinical impact 
both in diagnostics and in prediction of pregnancy after ART (8). One possibility to 
explain the differences in outcome of these sperm counts is laid in the variation in 
practice of semen analysis (SA) by laboratories (6,8).      
A same type of laboratory practice variation might be the origin of different 
pregnancy results after IUI. Despite the fact that there is a recommendation for 
both SA and sperm preparation for IUI (9), a recent literature review showed that 
the recommended methods for sperm preparation are characterized by a low 
level of evidence, insufficient literature and controversial results (10). On the other 
hand, from this literature review some tentative conclusions could be made for an 
optimal procedure. 
An overview of guideline adherence by laboratories of the technical stage of IUI 
is missing in literature. Based on results of an earlier survey (not published), we 
expect a lot of variation, despite the fact that many laboratories introduced the 
ISO 15189 medical laboratory standard and besides an improved version of the 
WHO manual (9). As in the clinical part of IUI, where optimal guideline adherence 
was reported to have important economical benefits (11), this inter-laboratory 
variation is undesirable. On the other hand, coupling this variation in laboratory 
methods to IUI pregnancy rates, may provide more evidence with respect to the 
optimum procedure as extracted from literature (10). 
Therefore the objective of this study is to survey the different laboratory IUI 
procedures, to associate these methods with IUI pregnancy results and to compare 
these outcomes with the conclusions of the literature review. As SA results are an 
important factor for IUI counseling (5,7,12), we also investigated the methods used 
54
CHAPTER 3
for SA. It is highlighted that the study is a laboratory survey and is not including 
individual patient data that can influence the pregnancy results of IUI. Moreover, 
the study was limited to the situation in Dutch fertility laboratories. As SA and IUI 
are performed on large scale in The Netherlands and the foreseen variation is 
high, a sanguine outcome can be expected, informative for other countries as well.
Materials and methods 
About hundred Dutch fertility laboratories participating in the regular external 
quality control program for SA were invited for this questionnaire survey study. 
In the Netherlands, the Dutch Foundation for Quality Assessment in Medical 
Laboratories (SKML) is a non-profit organization that organizes the external quality 
control of most Dutch laboratories performing SA. 
An invitation for the survey study was sent by e-mail to the laboratories, together 
with the weblink of the electronic questionnaire (Survey Monkey). One reminder 
was sent two weeks later. The responses were received in May and June, 2016. 
Questionnaire development
The questionnaire was developed based on previous survey studies (13-17), our 
literature study (10) and input of an expert panel. The questionnaire consisted 
of 46 questions. Most questions were closed-ended, open-ended questions were 
used when the respondents should present quantitative data.
The questionnaire was constructed in Dutch and was designed to obtain 
information on the used methodologies of SA and IUI. In part A, the type 
of laboratory, quality management system and staff on the laboratory was 
questioned. Part B consisted of questions about the technical performance of SA 
(i.e. assessment of concentration, morphology and motility assessment) and the 
laboratory procedures of IUI (e.g. advised ejaculatory abstinence, semen collection 
place, temperature during centrifugation/storage). In part C, participants were 
requested to present their data on IUI ongoing pregnancy (fetal heart beat after 
12 weeks of gestation) results in the period 2013-2015.
Statistical analyses
The results are presented as counts and percentages. The probability to become 
pregnant was modelled with logistic regression models, using the reported 
pregnancy results of 2013-2015. The dependent variable was pregnancy outcome 
(yes/no). The independent variables were semen collection place (at home or 
both in the clinic or at home), semen preparation technique (density gradient 
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centrifugation, washing, swim-up or swim-down), washing medium (HEPES or 
bicarbonate), temperature during storage (room temperature, body temperature 
or no storage), method of timing IUI (hCG administration, LH surge, ultrasound or 
a combination of these) and bed rest after insemination (direct mobilization or bed 
rest). The selection of independent variables was based on our literature review 
study (10). First, univariable logistic regression models were fitted. The statistically 
significant independent variables were included in a multivariable logistic regression 
analysis with forward selection based on the Wald test for selecting a set of variables 
predicting the probability to become pregnant (based on α=0.05). The crude odds 
ratios (ORs) with 95% confidence intervals (CIs) based on the univariable logistic 
regression model were estimated. The ORs with 95% CIs and the p-values of this 
final multivariable model are presented. The statistical analyses were performed 
using SPSS IBM Statistics 20.0 for Windows (Chicago, Illinois, USA).
Results
Ninety nine laboratories were invited for this study. A total 52 questionnaires was 
received on Survey Monkey (response rate of 52.5%). Of these respondents, 49 
completed the SA part and 48 the IUI part of the questionnaire. Pregnancy results 
were reported by 35 (2014/2015) or 36 (2013) laboratories.
Organization of the participating clinics
Most of the respondents characterized their laboratory as a clinical chemistry 
laboratory (73.1%), others as specialized fertility/embryology (15.4%), clinical 
microbiology (5.8%) or clinical pathology (5.8%) laboratories. Of the clinical 
chemistry laboratories, two indicated that their fertility procedures were performed 
at a separated, specialized fertility setting. A total of 536 laboratory technicians 
were involved in performing SA and 549 in performing sperm processing for IUI. 
On average, the mean number of IUI treatments per technician is 40 a year. Of the 
total group of employees responsible for performing SA and/or semen processing 
for IUI, 9 (1.6%) were qualified clinical embryologists, 4 (0.7%) possessed another 
(post-) master’s degree, 395 (68.6%) possessed a higher professional education, 
166 (28.8%) intermediate vocational education and 2 (0.3%) had other degrees.
An interdisciplinary meeting with the department of gynaecology was organized 
once a year in 23.1% of the laboratories, twice a year in 21.2%, three or four times 
a year in 9.6% and more than four times a year in 20.9% of the laboratories. One-
quarter of the participating laboratories indicated that such meeting did not take 
place at their clinic. Couples are treated following clinical IUI protocols with either a 
natural or stimulated cycle in most laboratories (93.8%). Couples in the remaining 
three clinics were offered only stimulated IUI cycles.
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About 60% of the laboratories stated that they perform an internal quality control 
program, where most of these programs (74.2%) included a component specified to 
SA. All included laboratories were accredited according to the ISO 15189 or similar.
Semen analysis
A total of 49 laboratories responded to the subset of questions about SA 
methodologies, one reaction was incomplete. For SA, the WHO 2010 reference 
values were most frequently used (75.5% of the laboratories), followed by the 
WHO 1999 reference values (20.4%). One laboratory combined the reference 
values of the WHO 2010 and a Dutch directive (18).
The reported methodologies for SA are summarized in Table 1. Recommendations 
of the WHO guideline on SA procedures are followed by a limited number of 
laboratories: sperm concentration is determined using the improved Neubauer 
hemocytometer in 55.1% of the laboratories. With respect to sperm motility, 
about 40% of the laboratories use the WHO 1999 criteria (i.e. rapidly progressive, 
slowly progressive, non-progressive and immotile), which is recommended by the 
ESHRE Special Interest Group Andrology in their Basic Course on Semen Analysis 
(19). Moreover, participants of this course are instructed to assess sperm motility 
at body temperature. This is followed by 80% of the laboratories, in most cases by 
using a microscope stage heater (92.3%). Sperm morphology assessment seems to 
be considered of limited interest, because only a small majority of the laboratories 
(n=25) performed this test during routine SA. Only two laboratories assess sperm 
morphology using the Papanicolaou stain. 
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Table 1. Description of the used methods during semen analysis in the participating laboratories. 




    Improved Neubauer
    Makler
    CellVision
    Bürker Türk
    Leja















    WHO 2010 
    WHO 1999








    Body temperature    
    Room temperature 









    DiffQuik
    Giemsa
    Papanicolaou
    Other











SA= semen analysis, WHO= World Health Organization
Laboratory procedures of IUI
Of the total group of respondents, 48 (92.3%) laboratories performed semen 
processing for IUI treatment. The majority of these, performed semen processing 
on six days (41.7%) or seven days (50.0%) a week, with no difference in clinical 
outcome. The used laboratory procedures of IUI are summarized in Table 2. The 
majority of the laboratories (72.9%) offered the couples the opportunity to collect 
semen both in the clinic and at home. In these clinics, semen collection usually 
took place at home in 25 laboratories (71.4%), at the clinic in 25.7% and only 
one laboratory stated that collection took place in both options at a comparable 
frequency. Moreover, 31.3% of the participating laboratories advised an ejaculatory 
abstinence period of 2-7 days before semen collection (WHO recommendation 
for SA). Other advised ejaculatory abstinence periods were 2 days (18.8%), 3 days 
(18.8%), 2-5 days (6.3%) or 5-7 days (6.3%). 
Most of the respondents (89.6%) reported routinely using density gradient 
centrifugation as semen preparation technique, followed by conventional washing 
(6.3%). The used density gradients were PureSpermR (Nidacon, Gothenberg, 
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Sweden) in 23.3% of the laboratories, SilSelectR (FertiPro, Beernem, Belgium) in 
65.1% of the laboratories and other, less common gradients (i.e. SpermGradR, 
SpermPrepR, SupraSpermR and SpermTecR) in 11.6% of the laboratories. The 
density gradients were used in a single layer (30.2%) or a double layer (69.8%). 
Table 2. Description of the used laboratory procedures of IUI in the participating laboratories. 




    At the clinic
    At home








    2-7 days
    2 days
    3 days
    2-5 days
    5-7 days















    Density gradient centrifugation
    Washing
    Swim-up










    Room temperature






    HEPES
    Bicarbonate








    Room temperature
    Body temperature
    No storage










Method of timing IUI
    hCG administration
    LH surge
    Ultrasound
    Combination











Bed rest after insemination
    Direct mobilization
    Bed rest
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All respondents centrifuged the semen samples at room temperature. HEPES 
buffered wash media (zwitterion-buffered) were commonly used and, pending 
insemination, the samples were stored at room temperature in 62.5% of the 
laboratories. Most laboratories reported a combination of methods for timing the 
moment of IUI (i.e. hCG administration, LH surge or ultrasound). The reported 
time intervals between ovulation induction and insemination ranged between 8 
and 48 hours (median 36 hours). After insemination, patients were asked to have 
bed rest for 10 minutes in one-quarter of the clinics, 10-15 minutes in 5.6% and 15 
minutes in 55.6% of the clinics, where others reported less common durations (i.e. 
5, 20 or 30 minutes). In 18.8% of the clinics no bed rest was advised.
Pregnancy results
About 35 laboratories presented their data on the number of performed SA, IUI 
cycles and the pregnancy rates in 2013-2015. Table 3 summarizes these data, 
together with the calculated pregnancy rates per cycle. Overall, a total of 42,071 
SA were performed in these clinics in the period of 2013-2015. Moreover, a total 
of 3,734 ongoing pregnancies were reported in 42,613 IUI cycles. Subsequently, 
the mean pregnancy rates per cycle were 9.4%, 9.6% and 9.6%, respectively, in 
2013, 2014 and 2015. Regarding the organization of the participating laboratories, 
specialized laboratories (i.e. fertility/embryology) performed on overage more SAs 
(1,171 vs. 346) and IUI treatments (763 vs. 286) than other laboratories (i.e. clinical 
chemistry, microbiology and pathology), while pregnancy rates were comparable 
(9.4% in specialized laboratories vs. 9.5% in others). This might indicate that both 
types of laboratories use the same indications and/or have the same variation in 
methods for IUI. Pregnancy rates were significantly lower in clinics performing IUI 5 
days a week, while these were comparable in clinics with either a 6 or 7 days service. 
Table 3. Total number of performed semen analyses and IUI cycles over the last years, together with the 
















Semen analyses 28 14,394 30 13,924 30 13,753
IUI cycles 38 14,407 38 13,639 38 14,567
Ongoing pregnancies 36 1,312 35 1,189 35 1,233
PR per cycle (mean of labs)*













PR= pregnancy rate, *  Sum of PRs per laboratory/number of laboratories, † Total number of pregnancies/
total number of cycles.
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In Table 4, the crude ORs from the univariable and the multivariable logistic 
regression models are presented. The probability to become pregnant was 
positively influenced by the use of a HEPES buffered washing medium compared 
to bicarbonate buffer (p=0.02) and by storage at room temperature compared 
to storage at body temperature (p=0.00). Higher pregnancy rates were also 
obtained in clinics that give the possibility to collect semen at home or in the 
clinic than in clinics that advice semen collection at home only (OR=0.71, 95%CI 
(0.59-0.87)).  Wash-only had a negative effect compared to density gradient 
centrifugation (OR=0.77, 95%CI (0.64-0.94)). Furthermore, the method of timing 
IUI was an independent variable, with a lower probability in the group using hCG 
administration (OR=0.80, 95%CI (0.73-0.87)). This model was based on data from 
33,233 reported cycles in the participating laboratories; in the other cycles were 
one or more variables missing.
Discussion with conclusions
As expected, this questionnaire survey study shows a wide variability of used 
methods on fertility laboratories in the Netherlands, especially for SA methods. 
With respect to IUI, some of the laboratory variables have a significant impact on 
reported pregnancy rates.
One possible explanation for the variation in methods may be found in the fact 
that the presented data give us an overview of the situation in 2016. Some of 
the respondents replied that the used methods were recently changed or that 
changes are planned in the near future due to re-organizations. This will especially 
bias the impact of different laboratory procedures on IUI outcome (Table 4), since 
the reported methods were not always used during the total study period 2013-
2015. The number of laboratories performing SA in the Netherlands is changing, 
mainly as a result of fusions of laboratories. This may lead to different points of 
view within the fused group of professionals.
In general, the measured variation is both alarming and interesting. Alarming, 
because by absence of reference material, a recommended and fully validated 
method is all we have. Using other, non-validated methods adds to the 
uncertainty associated with the quality of analysis and makes it inappropriate for 
laboratories to use WHO reference values. So, the situation could theoretically 
lead to inadequate patient selection for the different treatments and so possibly 
to lower results of these treatments. We have to be careful in this, because 
from this survey it is not clear whether or not alternative methods are validated 
against the WHO recommendations. Moreover, it should be mentioned that 
SA not only contributes to predicting pregnancy rates, but is also valuable in 
a wider andrological perspective: a poor result from SA should be a starting 
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point for further evaluation of the man’s health, e.g. by testicular ultrasound or 
endocrine examination. The interesting part of the variation is laid in the fact that 
all responding laboratories were accredited according to ISO 15189 (or CCKL, a 
national erstwhile standard similar to ISO) but that this is not a guarantee that 
they follow the WHO recommendations. A possible explanation may be that 
accrediting bodies do not refer to these recommendations as they are no official 
standard (9,20). A way to overcome this problem may be to write an ISO standard 
for SA and/or by implementing a check-list on SA by major scientific journals 
(Bjorndahl, 2016). On the other hand, these “top-down” strategies might not work 
as there apparently is a kind of resistance to follow the present recommendations. 
Table 4. The odds ratios of the laboratory procedures for the probability to become pregnant after an 
IUI treatment, based on the reported ongoing pregnancy rates 
Univariable Multivariable *
Characteristic n OR (95% CI) p-value OR (95% CI) p-value
Semen collection place
   At the clinic
   At home













   Density gradient centrifugation
   Washing
   Swim-up


























   HEPES









   Room temperature
   Body temperature













Method of timing IUI
   hCG administration
   LH surge
   Ultrasound



























Bed rest after insemination
   Direct mobilization








OR= odds ratio, CI= confidence interval, Ref= reference, - = no data to include, x= not included in the 
model 
* AUC of the model was 0.54 (95%CI (0.53-0.55)), Nagelkerke R2 < 0.001.
This resistance arose from previous versions of the WHO manual (21,22) that were 
judged as incomplete and their introduction did not result in the use of standardized 
materials and methods among fertility laboratories for SA (13-17) and IUI (14,23). 
The most recent WHO manual can also be discussed, especially with respect to 
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agreeability of the procedures. It can be expected that there is more willingness to 
implement recommendations with a higher level of evidence and/or simplicity. A 
good example of this is the examination of sperm morphology. In The Netherlands, 
this test is out of interest because gynaecologists mainly use the validated Hunault 
model as predictive tool for pregnancy (24,25). In this model, sperm morphology 
is not included as a parameter of relevance, which may lead to less willingness to 
perform the test or to perform it accurately. The questionnaire results confirm this 
hypothesis: only half of the laboratories perform sperm morphology assessment 
of which only two use the Papanicolaou stain, as described by the WHO. A similar 
result was found in France (26). The risk of not performing sperm morphology 
assessment is complex to speculate about, as on the one hand one might miss 
specific severe abnormalities which lead to infertility (e.g. globozoospermia, 100% 
short motile tails, 100% severe ERC and 100% stress induced elongated sperm 
heads) and, on the other hand, a poor performance may lead to unsuitability of the 
algorithm used for patient selection. With respect to the first point, The dilemma is 
that the incidence of these specific abnormalities is very low and therefore it will 
be difficult to train and instruct standard laboratories on these items. 
Next to agreeability, also interpretation of the WHO recommendations can be a 
source of variation. For example, the abstinence time for SA as advised by WHO (2-7 
days) is used by many laboratories also for IUI (table 2). The WHO does however 
not give recommendations on this aspect for IUI and shorter intervals are probably 
more effective for this treatment (27-29). The same is true for semen collection at 
home. As the WHO manual states that analysis should begin within one hour after 
ejaculation, this may be interpreted that there is some freedom in the sampling step. 
Some accreditation programs might see this as a high risk for loss of process control.
Next to the laboratory aspects, IUI guideline adherence in clinical studies was 
reported as far from optimal with a large variability between different hospitals 
(30). Even the use of a professional-directed strategy and a multi-faceted patient- 
and professional-oriented strategy did not improve the implementation of a set of 
clinical guideline recommendations (31). Like shortcomings in the performance of 
SA, this could lead to a less careful inclusion of patients, thereby decreasing the 
effectiveness of the treatment. So, with respect to IUI guidelines, implementation 
on the laboratory and clinic face similar problems. Moreover, this questionnaire 
study reported a limited number of team meetings with both clinic and laboratory 
professionals. We think that these interdisciplinary meetings, where clinical results 
should be systematically reviewed, are an important condition for best practice and 
quality improvement. A guideline combining both laboratory and clinical procedures 
could be the solution to overcome these problems. A first effort was made by 
reviewing the essential steps for the laboratory stage of IUI, including the pre and 
post laboratory processes (10), thereby overlapping parts of the clinical process. 
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From our literature review (10), two conclusions could be drawn. First, most of 
the laboratory steps were characterized by a low level of evidence and, second, 
if evidence is available, guidelines do not always recommend this best practice. 
Surprisingly, when comparing process variables from this questionnaire with the 
results of the literature review (10), it was found that there was an accordance of 
≥75% on variables with the highest level of evidence (level 1 evidence (32)). On 
the other hand, however, the review study reported no superior method for the 
variables which had significant influences on the probability to become pregnant in 
this study. So, it seems that this simple questionnaire study can further argument 
the results from literature. This is interesting, however caution is needed when 
interpreting some of these results, since these were based on a small group of 
fertility laboratories. For example, patients treated in clinics performing their IUI 
procedures during 5 days a week had a statistically significant lower probability to 
become pregnant (OR= 0.77, 95%CI (0.67-0.89)) compared to clinics with a 7 days 
week schedule. The first group, however, consists of only 3 laboratories. Another 
important remark is that this study included clinic specific data, while cycle specific 
data, including variables of the individual couples (age, stimulation protocol, etc), 
would be more accurate. It may seem, for instance, that semen collection at 
home was less successful than for clinics allowing both home and clinic collection. 
However, this association is not as per definition causal as patients were not 
allocated randomly to either situation. Furthermore, the predictive power (area 
under the ROC-curve) of the final model was low (AUC=0.54, 95%CI (0.53-0.55)). 
Altogether, the different laboratory procedures for both SA and IUI need more 
supporting evidence related to “best practice”, resulting in convincing guidelines 
which should be combined with clinical guidelines. A first step to reach this goal 
can be found in the most recent validation of the Hunault model in which, next to 
sperm motility, also sperm morphology and volume are included (33). In fact this 
is a recognition of previous studies in which all semen parameters were found 
to be relevant for predicting fertility (34-36) and this could be a motivation for 
laboratories to follow the guidelines and to improve their procedures. Furthermore, 
to constantly improve the guidelines, additional research is essential. The next 
step to evaluate the influences of laboratory procedures on pregnancy results 
is the use of well-designed, multicenter controlled (retrospective or prospective) 
trials using couple-specific data. Thereafter, an effort can be made to optimize 




1. Calhaz-Jorge C, de Geyter C, Kupka MS, de Mouzon J, Erb K, Mocanu E, Motrenko T, 
Scaravelli G, Wyns C, Goossens V & Embryology. EIVFMCftESoHR. Assisted reproductive 
technology in Europe, 2012: results generated from European registers by ESHRE. Hum 
Reprod 2016;31: 1638-1652.
2. Dyer S, Chambers GM, de Mouzon J, Nygren KG, Zegers-Hochschild F, Mansour R, 
Ishihara O, Banker M & Adamson GD. International Committee for Monitoring Assisted 
Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 
and 2010. Hum Reprod 2016;31: 1588-1609.
3. Ombelet W. Evidence-based recommendations for IUI in daily practice. Middle East 
Fertility Society Journal 2013;18: 4.
4. Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, Hill JA, 
Mastroianni L, Buster JE, Nakajima ST, Vogel DL & Canfield RE. Efficacy of superovulation 
and intrauterine insemination in the treatment of infertility. National Cooperative 
Reproductive Medicine Network. N Engl J Med 1999;340: 177-183.
5. Thijssen A, Creemers A, Van der Elst W, Creemers E, Vandormael E, Dhont N & Ombelet W. 
Predictive value of different covariates influencing pregnancy rate following intrauterine 
insemination with homologous semen: a prospective cohort study. Reprod Biomed 
Online 2017;34: 463-472.
6. Tomlinson M, Lewis S, Morroll D & British Fertility S. Sperm quality and its relationship 
to natural and assisted conception: British Fertility Society guidelines for practice. Hum 
Fertil (Camb) 2013;16: 175-193.
7. Lemmens L, Kos S, Beijer C, Brinkman JW, van der Horst FA, van den Hoven L, Kieslinger 
DC, van Trooyen-van Vrouwerff NJ, Wolthuis A, Hendriks JC, Wetzels AM & Semen 
Section of the Dutch Foundation for Quality Assessment in Medical L. Predictive value 
of sperm morphology and progressively motile sperm count for pregnancy outcomes in 
intrauterine insemination. Fertil Steril 2016;105: 1462-1468.
8. Gatimel N, Moreau J, Parinaud J & Leandri RD. Sperm morphology: assessment, 
pathophysiology, clinical relevance, and state of the art in 2017. Andrology 2017;5: 845-
862.
9. WHO. World Health Organization. Laboratory manual for the examination and processing 
of human semen. 5th edn, 2010. World Health Organization, Geneva.
10. Lemmens L, Kos S, Beijer C, Braat DDM, Nelen W, Wetzels AMM & Dutch Foundation for 
Quality Assessment in Medical L. Techniques used for IUI: is it time for a change? Hum 
Reprod 2017;32: 1835-1845.
11. Haagen EC, Nelen WL, Adang EM, Grol RP, Hermens RP & Kremer JA. Guideline adherence 
is worth the effort: a cost-effectiveness analysis in intrauterine insemination care. Human 
Reproduction 2013;28: 357-366.
12. Ombelet W, Dhont N, Thijssen A, Bosmans E & Kruger T. Semen quality and prediction 
of IUI success in male subfertility: a systematic review. Reprod Biomed Online 2014;28: 
300-309.
65
Optimization of laboratory procedures for intrauterine insemination
3
13. Helmerhorst FM, Oei SG, Bloemenkamp KW & Keirse MJ. Consistency and variation in 
fertility investigations in Europe. Hum Reprod 1995;10: 2027-2030.
14. Keel BA, Stembridge TW, Pineda G & Serafy NT. Lack of standardization in performance 
of the semen analysis among laboratories in the United States. Fertility and Sterility 
2002;78: 603-608.
15. Ombelet W, Pollet H, Bosmans E & Vereecken A. Results of a questionnaire on sperm 
morphology assessment. Hum Reprod 1997;12: 1015-1020.
16. Riddell D, Pacey A & Whittington K. Lack of compliance by UK andrology laboratories with 
World Health Organization recommendations for sperm morphology assessment. Hum 
Reprod 2005;20: 3441-3445.
17. Souter VL, Irvine DS & Templeton AA. Laboratory techniques for semen analysis: a 
Scottish survey. Health Bull (Edinb) 1997;55: 140-149.
18. KLEM/NVKC. Multidisciplinaire richtlijn Semenanalyse. 2011.
19. Barratt CLR, Bjorndahl L, Menkveld R & Mortimer D. ESHRE special interest group for 
andrology basic semen analysis course: a continued focus on accuracy, quality, efficiency 
and clinical relevance. Human Reproduction 2011;26: 3207-3212.
20. Bahadur G, Homburg R, Muneer A, Racich P, Alangaden T, Al-Habib A & Okolo S. First line 
fertility treatment strategies regarding IUI and IVF require clinical evidence. Hum Reprod 
2016;31: 1141-1146.
21. WHO. WHO laboratory manual for the examination of human semen and sperm-cervical 
mucus interaction. 3rd edn, 1992. Published on behalf of the World Health Organization 
by Cambridge University Press, Cambridge England ; New York, NY, USA.
22. WHO. WHO laboratory manual for the examination of human semen and sperm-cervical 
mucus interaction. 4th edn, 1999. Published on behalf of the World Health Organization 
by Cambridge University Press, Cambridge, UK ; New York, NY.
23. Penn HA, Windsperger A, Smith Z, Parekattil SJ, Kuang WW, Kolettis PN & Nangia AK. 
National semen analysis reference range reporting: adherence to the 1999 World Health 
Organization guidelines 10 years later. Fertil Steril 2011;95: 2320-2323.
24. Hunault CC, Habbema JD, Eijkemans MJ, Collins JA, Evers JL & te Velde ER. Two new 
prediction rules for spontaneous pregnancy leading to live birth among subfertile 
couples, based on the synthesis of three previous models. Hum Reprod 2004;19: 2019-
2026.
25. van der Steeg JW, Steures P, Eiikemans MJC, Habbema JDF, Hompes PGA, Broekmans FJ, 
van Dessel THJHM, Bossuyt PMM, van der Veen F & Mol BWJ. Pregnancy is predictable: a 
large-scale prospective external validation of the prediction of spontaneous pregnancy 
in subfertile couples - Reply. Human Reproduction 2007;22: 2345-2346.
26. Gatimel N, Mansoux L, Moreau J, Parinaud J & Leandri RD. Continued existence of 
significant disparities in the technical practices of sperm morphology assessment and 




27. Bahadur G, Almossawi O, Zeirideen Zaid R, Ilahibuccus A, Al-Habib A, Muneer A & Okolo 
S. Semen characteristics in consecutive ejaculates with short abstinence in subfertile 
males. Reprod Biomed Online 2016;32: 323-328.
28. Levitas E, Lunenfeld E, Weiss N, Friger M, Har-Vardi I, Koifman A & Potashnik G. 
Relationship between the duration of sexual abstinence and semen quality: analysis of 
9,489 semen samples. Fertil Steril 2005;83: 1680-1686.
29. Levitas E, Lunenfeld E, Weisz N, Friger M, Har-Vardi I & Potashnik G. Relationship between 
sexual abstinence duration and the acrosome index in teratozoospermic semen: analysis 
of 1800 semen samples. Andrologia 2006;38: 110-112.
30. Haagen EC, Nelen WL, Grol RP, Braat DD, Hermens RP & Kremer JA. Variation in guideline 
adherence in intrauterine insemination care. Reprod Biomed Online 2010;20: 533-542.
31. Mourad SM, Hermens RPMG, Liefers J, Akkermans RP, Zielhuis GA, Adang E, Grol RPTM, 
Nelen WLDM & Kremer JAM. A multi-faceted strategy to improve the use of national 
fertility guidelines; a cluster-randomized controlled trial. Human Reproduction 2011;26: 
817-826.
32. NICE. National Institute for Heatlh and Clinical Excellence. Fertility: Assessment and 
Treatment for People with Fertility Problems, 2013, London.
33. Bensdorp AJ, van der Steeg JW, Steures P, Habbema JDF, Hompes PGA, Bossuyt PMM, van 
der Veen F, Mol BWJ, Eijkemans MJC & group Cs. (2017) A revised prediction model for 
natural conception. Reprod Biomed Online 2017;34: 619-626.
34. Barratt CLR, Bjorndahl L, De Jonge CJ, Lamb DJ, Osorio Martini F, McLachlan R, Oates 
RD, van der Poel S, St John B, Sigman M, Sokol R & Tournaye H. The diagnosis of male 
infertility: an analysis of the evidence to support the development of global WHO 
guidance-challenges and future research opportunities. Hum Reprod Update 2017;23: 
660-680.
35. Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C, Carson SA, 
Cisneros P, Steinkampf MP, Hill JA, Xu D, Vogel DL & National Cooperative Reproductive 
Medicine N. Sperm morphology, motility, and concentration in fertile and infertile men. 
N Engl J Med 2001;345: 1388-1393.
36. Jedrzejczak P, Taszarek-Hauke G, Hauke J, Pawelczyk L & Duleba AJ. Prediction of 
spontaneous conception based on semen parameters. Int J Androl 2008;31: 499-507.
67
Optimization of laboratory procedures for intrauterine insemination
3

4CHAPTER 4Predictive value of sperm morphology and progressively motile sperm count for pregnancy outcomes in intrauterine insemination 
L. Lemmens, S. Kos, C. Beijer, J.W. Brinkman, F.A.L. van der Horst, L. van den 
Hoven, D.C. Kieslinger, N.J. van Trooyen-van Vrouwerff, A. Wolthuis, J.C.M. 
Hendriks, A.M.M. Wetzels, for section semen of the Dutch Foundation for Quality 
Assessment in Medical Laboratories




Objective: To investigate the value of sperm parameters to predict an ongoing 
pregnancy outcome in couples treated with intrauterine insemination (IUI), during 
a methodologically stable period of time.
Design: Retrospective, observational study with logistic regression analyses.
Setting: University hospital.
Patient(s): A total of 1,166 couples visiting the fertility laboratory for their first IUI 
episode, including 4,251 IUI cycles. 
Intervention(s): none
Main Outcome Measure(s): Sperm morphology, total progressively motile sperm 
count (TPMSC), and number of inseminated progressively motile spermatozoa 
(NIPMS); odds ratios (ORs) of the sperm parameters after the first IUI cycle and 
the first finished IUI episode; discriminatory accuracy of the multivariable model.
Results: None of the sperm parameters was of predictive value for pregnancy 
after the first IUI cycle. In the first finished IUI episode, a positive relationship was 
found for ≤4% of morphologically normal spermatozoa (OR 1.39) and a moderate 
NIPMS (5–10 million; OR 1.73). Low NIPMS showed a negative relation (%1 million; 
OR 0.42). The TPMSC had no predictive value. The multivariable model (i.e., sperm 
morphology, NIPMS, female age, male age, and the number of cycles in the 
episode) had a moderate discriminatory accuracy (area under the curve 0.73).
Conclusion: Intrauterine insemination is especially relevant for couples with 
moderate male factor infertility (sperm morphology ≤4%, NIPMS 5–10 million). 
In the multivariable model, however, the predictive power of these sperm 
parameters is rather low. 
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Introduction
In a previous study, we evaluated the prognostic value of sperm morphology 
to predict pregnancy outcomes in couples treated with in vitro fertilization (IVF) 
or intracytoplasmic sperm injection (ICSI) (1). Our research filled a gap in the 
literature on the subject, which dated from the period before the introduction of 
ICSI in the 1990s and thus needed an update. Over the past decades, the reported 
percentages of morphologically normal spermatozoa has decreased with the 
introduction of stricter criteria and the tendency toward lower reference values 
(2). This is a disturbing factor in the use of sperm morphology as a prognostic 
factor for the probability of achieving a pregnancy. The strength of our study (1) 
was the selection of a stable period of time (i.e., 2004 to 2011) with respect to 
the methodology of sperm morphology assessment. In contrast to older studies, 
as reviewed by Coetzee et al. (3), we concluded that sperm morphology has no 
prognostic value in individual in vitro fertilization (IVF) and ICSI patients.
However, we can hypothesize that the role of sperm factors in intrauterine 
insemination (IUI) is different from their role in IVF and ICSI. Literature reviews reveal 
an ongoing debate on the value of sperm parameters as predictors of IUI outcome 
(4-6). More specifically, conflicting results have been reported for the influence 
of sperm morphology assessment using strict criteria on pregnancy outcomes 
with IUI (7-16). These studies are characterized by a lack of standardization, so 
repeating our previous study with couples treated with IUI is valuable.
Besides sperm morphology, there is disagreement about the predictive value 
of the total progressively motile sperm count (TPMSC) to predict IUI outcomes 
(6). In their review, Ombelet et al. (4) stated that the TPMSC has a substantial 
discriminative value. Others, however, have concluded that the TPMSC has poor 
sensitivity for selecting the couples most likely to conceive with IUI, but high 
specificity for identifying the couples unlikely to conceive with IUI (6,17,18). The 
required number of inseminated progressively motile spermatozoa (NIPMS) is 
under discussion as well, although in general a minimum of 5 million spermatozoa 
is stated as accurate (2).
We investigated the value of sperm parameters to predict ongoing pregnancy 
outcomes in couples treated with IUI during a methodologically stable period 
of time. The sperm parameters studied were sperm morphology and TPMSC, 
both assessed during fertility workup, and NIPMS assessed at the time of IUI. 
Additionally, the predictive power of these parameters for the probability of 





In this retrospective, observational study, anonymized data sets were included of 
all couples who visited the fertility laboratory of the Radboud University Medical 
Centre Nijmegen for confirmed, finished IUI episode between January 1, 2004, and 
June 30, 2013. A finished episode is defined as a sequence of treatment cycles 
that ends when a cycle results in a pregnancy or when IUI treatment is stopped. 
Records were excluded when data on pregnancy outcome or sperm parameters 
were missing. In cases where multiple assessments of morphology and/or TPMSC 
were performed, the data from the most recent fertility workup were used. The 
ethics review board of the Radboud University Medical Center Nijmegen provided 
approval for this study. 
Study period
The study period was based on the stability of methods for semen analysis and 
semen preparation. In our previous study (1), we established this period between 
the years 2004 and 2011. Our methods did not change since 2011; the period for 
the present study was extended to June 30, 2013.
Semen analysis
Sperm samples were collected preferably after 2 to 3 days of ejaculatory abstinence 
and were delivered to the laboratory within 1 hour. Semen analysis was performed 
as described in our previous study (1). Briefly, the volume was determined 
by aspirating the ejaculate with a scaled pipette, the sperm concentration was 
determined by counting in a Makler chamber, and the fraction of progressively 
motile spermatozoa was determined in a 20-μm deep wet preparation. For the 
sperm morphology assessment, a small drop of semen was mixed with an equal 
amount of aniline blue/eosin solution, which consisted of 2 g of eosin yellow and 25 
g of aniline blue (VWR) in 100 mL of phosphate-buffered saline (Gibco-Invitrogen) 
and 1 mL of ethanol. The mix was spread on a microscopic slide and flame fixed. 
A total of 200 spermatozoa per slide were evaluated according to the current 
World Health Organization (WHO) criteria at an original magnification of ×1,000 
(19, 20). From this sperm assessment during the fertility workup, the percentage 
of morphologically normal spermatozoa and the TPMSC were calculated.
Intrauterine insemination
We performed IUI in natural cycles or in cycles with mild ovarian stimulation. The 
semen preparation was performed using a one step (80%) PureSperm (Nidacon) 
gradient after dilution of the semen with 5-mL of wash medium (human tubal 
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fluid medium; Gynotec) supplemented with 10% albumin (GPO; Sanquin). After 
centrifugation (500 × g), the semen was washed with wash medium, and the NIPMS 
was assessed in the samples used for insemination. The sperm variables were 
determined as described earlier, and the NIPMS was calculated by multiplying the 
volume by sperm concentration and the fraction of progressively motile sperm 
of the prepared semen. Approximately 2 weeks after insemination, a pregnancy 
test was performed; 8 to 10 weeks later, an ultrasound examination was used to 
confirm an ongoing pregnancy.
Assessment of variables
The main variables of interest in the predictive model were the percentage 
morphologically normal spermatozoa and the TPMSC. Both diagnostic sperm 
parameters were assessed routinely during the fertility workup. Additionally, the 
NIPMS was analyzed to investigate whether information about the inseminated 
sample improved the predictive value of the model. Note that this sample was not 
the same as the sample used during the fertility workup. Besides sperm parameters, 
we evaluated the effects of underlying female factor etiology (i.e., ovulatory 
dysfunction, cervical factor, endometriosis, or tubal/uterine abnormalities), female 
age, male age, and the number of IUI cycles. Moreover, we studied the number of 
IUI cycles until an ongoing pregnancy was established within the first finished IUI 
episode. The outcome variables were ongoing pregnancy after the first IUI cycle 
and ongoing pregnancy in the first finished IUI episode of a couple.
Statistical methods
The baseline population characteristics are presented as a median and range 
or as a count and percentage. Based on previous reviews (4, 5), we categorized 
the percentage morphologically normal spermatozoa into two groups: ≤4% and 
>4%. The TPMSC was categorized into four groups (i.e., ≤20 million, 20–50 million, 
50–100 million, and >100 million), as was the NIPMS (i.e., ≤1 million, 1–5 million, 
5–10 million, and >10 million). The NIPMS was assessed at each IUI cycle, so the 
mean NIPMS of the first finished IUI episode of the couple was calculated before 
categorization.
The different cycles within a couple are not independent of each other, so ignoring 
this dependency during data analysis might result in incorrect conclusions (21). 
For this reason, we studied the probability of becoming pregnant in both the first 
IUI cycle and the first finished IUI episode. In the first instance, univariable logistic 
regression analysis was used to determine the influence of sperm morphology 
and TPMSC. The dependent variable was pregnancy outcome after the first IUI 
cycle and in the first finished IUI episode, respectively. The independent variable 
was sperm morphology (≤4% or >4%) or TPMSC (≤20 million, 20–50 million, 
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50–100 million, or >100 million). Similar logistic regression was used to study the 
other IUI-associated variables. The crude odds ratios (ORs) with 95% confidence 
interval (CI) were calculated.
Subsequently, multivariable logistic regression with a forward selection procedure 
was used to identify those variables that independently predict the probability of 
becoming pregnant after the first IUI cycle and in the first finished IUI episode, 
respectively. The adjusted ORs with the appropriate 95% CI and the discriminatory 
accuracy (i.e., the area under the receiver operating characteristic curve [AUC]) 
of the final model are presented. All statistical analyses were performed using 
SPSS IBM Statistics 20.0 for Windows.The baseline population characteristics are 
presented with their median and range or with their count and percentage. Based 
on previous reviews (4, 5), the percentage morphologically normal spermatozoa 
was categorized into two groups (i.e. ≤4% and >4%). The TPMSC was categorized 
into four groups (i.e. ≤20 million, 20-50 million, 50-100 million and >100 million), 
as well as the NIPMS (i.e. ≤1 million, 1-5 million, 5-10 million and >10 million). The 
NIPMS was assessed at each IUI cycle and, therefore, the mean NIPMS of the first 
finished IUI episode of the couple was calculated, prior to categorization. 
Results
In Table 1, the baseline characteristics of the total population and of the two 
groups by percentage of morphologically normal spermatozoa are shown. In 
total, 1,166 couples with 4,251 IUI cycles were included in this study. Of these, 112 
couples (9.6%) became pregnant after their first IUI cycle, and 329 (28.2%) became 
pregnant in their first finished IUI episode. The percentage of morphologically 
normal spermatozoa was ≤4% in 444 couples and >4% in 629 couples. As expected, 
the higher levels of TPMSC (i.e., >100 million) and NIPMS (i.e., >10 million) as well 
as the number of couples with underlying female factor infertility were more 
frequently observed in the group with >4% normal sperm morphology than in the 
group with ≤4% normal sperm morphology. The ongoing pregnancy rates in the 
first IUI cycle were comparable in these two groups (10.8% and 9.2%, respectively). 
Surprisingly, the group with ≤4% normal sperm morphology had the highest 
ongoing pregnancy rate after the first finished IUI episode (32.9% vs. 26.1%).
The descriptive statistics of the four TPMSC groups are summarized in Table 2. 
With respect to the ongoing pregnancy rate, the four groups showed comparable 
results in both the first IUI cycle (9.4%, 10.0%, 8.5%, and 10.8%, respectively) 
and the first finished IUI episode (29.3%, 31.5%, 25.6%, and 28.8%, respectively). 
The increase in TPMSC was related to the increased percentage of couples with 
underlying female factor infertility (23.9% toward 38.1%) and with unexplained 
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infertility (7.4% toward 48.3%). The percentage of couples with NIPMS >10 million 
increased with higher values of the TPMSC (15.2% toward 87.7%).
First IUI cycle
In Table 3, the ORs are presented of the probability to become pregnant after the 
first IUI cycle and in the first finished IUI episode, respectively, using univariable 
logistic regression. Both the percentage of morphologically normal spermatozoa 
and the TPMSC were not statistically significant when related to the probability to 
become pregnant after the first cycle. It turned out that female age and male age 
were the only variables that were statistically significantly related to the probability 
of becoming pregnant after the first IUI cycle. A lower probability to become 
pregnant was related to both increased female age (OR 0.93; 95% CI, 0.89–0.98) 
and increased male age (OR 0.96; 95% CI, 0.92–1.00). Only female age was found to 
be predictive in multivariable regression analyses (Table 4). The predictive power 
of this model, however, was rather low (AUC 0.58; 95% CI, 0.53–0.64).
First finished IUI episode
The probability of becoming pregnant in the first finished IUI episode was higher 
in the group with normal sperm morphology of ≤4% as compared with the group 
with >4% morphologically normal spermatozoa (OR 1.39; 95% CI, 1.06–1.81) (Table 
3). The group with a NIPMS ≤1 million showed a statistically significant lower 
probability (OR 0.42; 95% CI, 0.23–0.76) and the group with a NIPMS between 5 
and 10 million a higher probability of becoming pregnant (OR 1.73; 95% CI, 1.21–
2.46) compared with the group with a NIPMS >10 million. Sperm morphology and 
NIPMS were also independent predictors of the probability to become pregnant in 
the multivariable analysis (Table 4).
The probability of becoming pregnant in the first finished IUI episode was 
negatively influenced by higher female age (OR 0.92; 95% CI, 0.88–0.96), higher 
male age (OR 0.97; 95% CI, 0.94–1.00), and an increasing number of cycles within 
the episode (OR 0.73; 95% CI, 0.68–0.78). This model was based on data from 
1,072 couples; the other couples were excluded because one or more variables 




This study reveals that couples with a lower percentage of morphologically normal 
spermatozoa (i.e., ≤4%) and a moderate NIPMS (i.e., 5–10 million) had the highest 
probability of becoming pregnant in the first finished IUI episode. In couples with a 
NIPMS of ≤1 million this probability was lower. The TPMSC had no predictive value 
in this perspective. In general, the predictive power of the semen parameters was 
limited, and it seems that especially female factors were critical for predicting the 
probability of becoming pregnant in individual couples.
Table 1. Descriptive statistics of the first finished IUI episode of couples, assorted by the group of 
percentage morphologically normal spermatozoa
Total group
(n=1,166)
Percentage morphologically normal 
spermatozoa







Female age 33 (21-41) 32 (21-41) 33 (21-41)
Male age 35 (23-67) 35 (24-57) 35 (23-67)
Etiology factor
   female factor














   ≤20 million
   20-50 million
   50-100 million 
   >100 million
































   ≤1 million
   <5 million
   5-10 million
   >10 million













































Nr of cycles in episode 3 (1-21) 3 (1-14) 3 (1-21)
Nr of cycles till pregnancy * 2 (1-11) 2 (1-11) 2 (1-11)
*based on the number of cycles with an ongoing pregnancy in the first finished IUI episode 
TPMSC= total progressively motile sperm count, NIPMS= number of inseminated progressively motile 
spermatozoa,  
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Table 2. Descriptive statistics of the first finished IUI episode of couples, assorted by the group of total 
progressively motile sperm count (TPMSC)

















Female age 32 (21-41) 33 (21-41) 33 (22-41) 34 (22-41)
Male age 35 (23-67) 35 (25-56) 35 (24-56) 36 (24-53)
Etiology factor
   female factor


















   ≤1 million
   1-5 million
   5-10 million
   >10 million



























































Nr of cycles in episode 3 (1-21) 3 (1-12) 3 (1-15) 3 (1-12)
Nr of cycles till pregnancy * 2 (1-11) 2 (1-9) 2 (1-7) 2 (1-9)
*based on the number of cycles with an ongoing pregnancy in the first finished IUI episode 
OP= ongoing pregnancy. NIPMS= number of inseminated progressively motile spermatozoa. TPMSC and 
NIPMS are measured as volume × concentration × progressively motile spermatozoa  
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Table 3. The odds ratios of the sperm parameters and other IUI-associated variables for predicting the 
probability to become pregnant after the first IUI treatment of a couple and within their first episode, 
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   ≤20 million 
   20-50 million
   50-100 million






















   ≤1 million 
   1-5 million
   5-10 million





















Female age (per year) 1,166 0.93 (0.89-0.98) 0.91 (0.88-0.94)
Male age (per year) 1,166 0.96 (0.92-1.00) 0.95 (0.92-0.97)
Etiology female factor
   no female factor












   no unexplained factor











Nr of cycles in episode (per cycle) 1,166 NA 0.79 (0.74-0.85)
OR=odds ratio, CI=confidence interval, TPMSC=total progressively motile sperm count, NIPMS= number 
of inseminated progressively motile spermatozoa, Ref= reference, NA= not applicable
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Table 4. The adjusted odds ratios of the variables associated with the probability to become pregnant 
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   ≤1 million
   1-5 million
   5-10 million













Female age (per year) 0.94 (0.90-0.99) 0.92 (0.88-0.96)
Male age (per year) - 0.97 (0.94-1.00)
Nr of cycles in episode (per cycle) - 0.73 (0.68-0.78)
OR=odds ratio, CI=confidence interval, NIPMS= number of inseminated progressively motile spermato-
zoa, Ref= reference, - = not included in model  
AUC first IUI cycle= 0.58 (95%CI (0.53-0.64)); AUC first IUI episode= 0.73 (95%CI (0.70-0.77))
It is interesting that the univariable model showed a higher probability of becoming 
pregnant in the first finished IUI episode for couples with ≤4% morphologically 
normal spermatozoa. In combination with the findings for NIPMS, this would 
mean that IUI is an especially relevant treatment for moderate male factor 
infertility, which is in accordance with most standards in infertility treatment (22). 
In contrast to our results, most studies have indicated that lower percentages of 
morphologically normal spermatozoa result in a lower probability of becoming 
pregnant (7-11,14,15,23). More important, the recommendations of some studies 
contradict our findings: couples with ≤4% normal sperm morphology have been 
advised to undergo IVF or ICSI instead of IUI (7,13).
Our results would intuitively make sense if infertile couples with good sperm 
quality were more frequently diagnosed with female factor infertility. The baseline 
characteristics of the study population underline this effect. Consequently, it is 
likely that the presence of female factors affects the relation between semen 
parameters and pregnancy outcome. When female factors are excluded, however, 
the probability of becoming pregnant based on semen parameters does not 
change in the opposite direction. Instead, the probability to become pregnant 
even increased in couples with ≤4% morphologically normal spermatozoa (OR 
1.58; 95% CI, 1.13–2.22).
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These apparently contradictory results raise the question of whether sperm 
morphology is an adequate predictor for the outcome of IUI. This view is supported 
by others (12,16,24). Note that it is also possible that the current WHO classification 
system may be inadequate (i.e., too strict criteria) but sperm morphology itself still 
could be an important parameter. It might be useful to consider the development 
of a new classification system.
Another striking result is that the TPMSC showed no prognostic value to predict 
the probability of becoming pregnant in couples with IUI treatment. Other studies 
have shown that TPMSC is of value when choosing between IUI and IVF or ICSI 
(17,25-27), and TPMSC has been described as a relatively good indicator for male 
factor infertility in general (27). Because of the lack of consensus, we additionally 
evaluated the threshold levels of the TPMSC as reported by others; we found no 
prognostic capacity (results not shown). In contrast to TPMSC, NIPMS was relevant 
in predicting the ongoing pregnancy rate after IUI. This is in agreement with the 
literature (2,4,6,10).
The final, multivariable model (Table 4) shows that the ongoing pregnancy rate in 
couples undergoing IUI was negatively influenced by a higher (>4%) percentage 
of morphologically normal spermatozoa, NIPMS of ≤1 million, higher female age, 
higher male age, and higher number of cycles within the episode. The predictive 
value of this model can be argued. Ideally, a prognosis is made between the fertility 
workup and the start of the treatment. At that time, the NIPMS and number of 
cycles within the episode are still unknown. When we excluded both variables 
from the final model, the receiver operating characteristic curve reported a lower 
discriminatory accuracy (AUC 0.73 toward 0.62). Furthermore, the predictive 
power hardly decreased when the sperm parameters were excluded from the 
final model (i.e., percentage of morphologically normal spermatozoa and NIPMS) 
(AUC 0.73 toward 0.69). Thus, this strengthens the conclusion that the predictive 
value of the sperm parameters for pregnancy outcomes in couples treated with IUI 
can be discussed. On the other hand, for most prediction models in reproductive 
medicine the discriminatory performance is low to moderate (28). From this 
perspective, every (small) addition toward a higher AUC is welcome.
To explain the different findings among the studies, some remarks can be made 
with respect to the study design and methods. First, several factors are related 
to the outcome of IUI (29-31), with the underlying etiology of infertility being one 
of them (32-34). Some researchers included couples with all etiologies in their 
study population. Among these latter studies, there was substantial diversity in 
the underlying etiology of infertility and the presence of different confounders 
and determinants within the study population (e.g., female age). Others stated 
that influences of semen parameters should be studied only in couples with male 
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factor infertility. All other etiologies of infertility should be excluded and the results 
corrected for confounding factors (27). These different policies with respect to the 
study population will likely result in different findings.
Second, among laboratories and clinics, there is wide variation in the methods of 
sperm preparation and semen analysis, the use or nonuse of different ovulation 
induction regimens, and the period of ejaculatory abstinence before IUI (4, 30, 
35). In particular, the interpretation of the strict criteria for sperm morphology 
assessment has resulted in a decline over time in the reported percentages of 
morphologically normal spermatozoa (1, 36). In our study, we overcame this 
problem by selecting a study period within a methodologically stable period of 
time. Additionally, a longer time interval between fertility workup and the actual 
insemination might influence the adequacy of the prediction.
Finally, the way of applying statistics can lead to different results. Most studies did 
not take into account that the different cycles within a couple are not independent 
of each other and that, consequently, correlation could be present among the 
cycles within a couple. Standard statistical tests, however, lean on the assumption 
of independent observations; otherwise, they will result in other (too small) 
standard errors of the estimates, leading to incorrect significant results (21, 37). 
To overcome this problem of correlated cycles, we used the pregnancy outcomes 
in the first IUI cycle and in the summarized data of the first finished IUI episode. A 
downside of this method, however, is that it does not cover the variability of the 
individual IUI cycles. We recommend that future studies should analyze their data 
with adequate statistical methods, taking correlated data into account, such as the 
generalized estimating equations or multilevel analyses (38-40).
In our study, we took many factors of influence into account. Along with the 
methodologically stable period with respect to semen analysis and adequate 
statistics, we checked for the influences of ejaculatory abstinence, type of ovulation 
induction, and the time interval between the fertility workup and IUI on the 
probability of becoming pregnant. No effects were found (results not shown). Still, 
it would be valuable to set up a prospective, multicenter study with clear inclusion 
of couples, sound statistics, and standardized and controlled protocols for semen 
analysis, semen preparation, fertility workup, and the IUI procedure in general. This 
will provide an opportunity to develop a better prognostic model. Accurate study 
design also would be helpful for reconsidering the accuracy of the percentage of 
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Semen analysis is characterized by high levels of intra- and inter- laboratory 
variability, due to a low level of standardization, high subjectivity of the assessments 
and problems with automated procedures. To improve consistency of laboratory 
results, quality control and training of technicians are important requisites. The 
goals of this study are to evaluate the results of an external quality control (EQC) 
program and standardized training by ESHRE Basic Semen Analysis Courses (BSAC) 
on the variability in manual assessments of semen parameters. We performed 
retrospective analysis of (1) inter-laboratory variability in the Dutch EQC program, 
and of (2) the inter-observer variability in BSAC’s in The Netherlands, including 
the sperm parameters concentration, motility and morphology. EQC data showed 
that the inter-laboratory coefficient of variation (CV) for concentration assessment 
decreased (range of 24.0-97.5% into 12.7-20.9%), but not for morphology and 
motility assessments. Morphology assessment showed highest CVs (up to 375%), 
with many outliers in the period 2007-2014. During BSAC a significant reduction 
of inter-observer variability could be established for all parameters (p<0.05). 
Explanations for the absence of an effect on the CV in the EQC program might be 
found in the facts that motility assessment was introduced in 2008 and the criteria 
for morphology assessment changed. BSAC results might have been influenced 
by the pre-training level of participants and the influence of external factors. Both 
EQC and training show positive effects on reducing variability, despite the fact that 
laboratories have a low willingness to change their methods towards standards. 
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Introduction
The actual clinical value of semen analysis has been discussed for several years 
(1), due to, among others, a lack of standardization of the methodologies used 
for semen analysis and sperm preparation for fertility treatments (2,3,4,5) and 
the ongoing debate on the predictive value of sperm parameters for fertility (6). 
Even the introduction of laboratory manuals by the World Health Organization 
(WHO) since 1980 (7,8,9,10,11) did not result in the desired level of adherence and, 
over the years, the used methods remained highly variable between laboratories 
especially for morphology assessment (2,3,4,12,13). Next to standardization 
of used methods, another pitfall of semen analysis is the subjectivity of the 
assessment, characterized by intra- and inter-observer variability, as well as inter-
laboratory variability. As a result, the quality of male infertility diagnostics might 
be impaired and, thereby, result in an inappropriate choice of treatment (14).
One strategy to measure intra- and inter-laboratory variability and the lack of 
standardization is to implement internal (IQC) and external quality control (EQC) 
programs. In different reports, EQC results showed a reduction of inter-laboratory 
variability over time for the three main aspects of semen analysis: sperm 
concentration, morphology and motility (15,16). IQC is an important requisite 
to improve consistency of analysis results within one laboratory, for example 
from one day of measurement to another (17,18). Both IQC and EQC are tools to 
evaluate whether procedures are effective, leading to a lower level of variability 
(19) and improved standardization over the years (16).
Training of technicians is another prerequisite to implement standardized methods 
and to minimize intra- and inter-observer variability. Reported immediate beneficial 
effects of semen analysis training were a substantial reduction of the variability 
in all aspects of semen analysis was reached within only a few days of training 
(14,22,23,24,25,26,27,28). On the long-term, training showed increased awareness of 
the need for standardization and even significant changes in used methods (27,29,30).
In the Netherlands, both quality control and training have been offered for several 
years. However, we showed in a previous study, that there is still a wide variability 
in used methods for semen analysis (4). Moreover, some of the recommended 
methods by the WHO were followed by rather small groups of the laboratories, for 
example the used counting chamber (~50%) and the staining method for morphology 
assessment (~10%) (4). Since the willingness of Dutch laboratories towards WHO 
recommendations was rather low, we expect that this could influence the impact 
of both requisites on the variability of semen analysis results. The objective of this 
study is therefore, to evaluate the impact over time on the variability of semen 
analysis results, shown by the Dutch EQC program and by the standardized training 
by the Dutch version of the basic semen analysis courses (BSAC) provided by the 





In the Netherlands, the Dutch Foundation for Quality Assessment in Medical 
Laboratories (SKML) distributes validated samples and digital data for the 
analysis of sperm characteristics, including the sperm parameters concentration, 
percentage of morphologically normal spermatozoa and percentage of motile 
spermatozoa (29). Participants of the regular EQC program are mainly fertility 
laboratories, clinical chemistry laboratories and microbiological laboratories. 
Since the start of the program, about 100 laboratories participate in the EQC 
program each year. Two samples for assessment of concentration, morphology 
and motility are distributed on a quarterly basis (i.e. March, June, September and 
December) and should, preferably, be evaluated by the technician in charge. In the 
period 2001-2018, 72 SKML distributions (144 samples) were assessed for sperm 
concentration and morphology as part of the EQC program. Motility assessment 
was included in the program since 2013; resulting in 48 samples assessed in 24 
distributes in the period 2013-2018. 
With permission of the local ethical board, EQC semen samples consisted of 
pooled semen that remained after semen analysis or IVF from men who visited 
the fertility laboratory of the Radboud University Medical Center and the clinical 
chemistry laboratory of the Sint Antonius Hospital. Semen used for concentration 
measures was prepared by density gradient centrifugation, diluted with Hayem’s 
dilution (Boom, the Netherlands), stored at 4°C and sent to the participants in 0.4 
ml aliquots. For morphology assessment, a small drop of semen (5 µl) was spread 
and air-dried on a microscopic slide. The participants were instructed about the 
preferred staining method. For motility assessment, semen was filmed in a Makler 
chamber at a magnification of x200 with phase contrast illumination. Each video 
consisted of two microscopic fields, each filmed for 40 seconds. Participants should 
evaluate motility of 200 spermatozoa of the samples according to WHO 1999 (i.e. 
rapidly progressive, slowly progressive, non-progressive and immotile) (8) or WHO 
2010 (i.e. progressive, non-progressive and immotile) (7). Results of all participating 
laboratories were included in this study, irrespective of their used methods.
BSAC
To evaluate short-term effects of training, results obtained during BSAC were 
used. The BSAC has been given twice a year since 2008 at the Radboud University 
Medical Center. It has been offered to laboratory staff aiming to reduce variability 
and increase standardization of semen analysis. Course content is provided by 
the ESHRE Special Interest Group for Andrology (SIGA), is based on the prevailing 
WHO laboratory guideline and has been updated regularly in response to new 
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findings and publications (30). The training includes all aspects of standard semen 
analysis and lasts four days. A more detailed description of the training schedule 
and course content is described by others (25).
At the start of the course, participants assessed semen parameters (i.e. 
concentration, morphology, vitality and motility) of two samples, without having 
had any training (pre-test measurements). These parameters were assessed 
again for two samples after one day of theoretical and practical training (training 
measurements). At the end of the week, BSAC was completed with a practical 
examination, including assessment of all semen parameters of two more samples 
(exam measurements). It is important to note that different semen samples were 
used for the pre-test, training and examination and that the vitality results were 
not included in this evaluation study. All samples consisted of waste semen from 
men who visited the fertility laboratory of the Radboud University Medical Center.
Statistical analyses
Results of the EQC program, in the period 2001-2018 were presented as means 
and coefficient of variation (CV) per sample for all semen parameters. The results 
of all participating laboratories were used, irrespective of used methods. During 
BSAC, participants analyzed two different samples during pre-test, training and 
exam. The mean of both measurements was calculated. Accordingly, the CVs of all 
measurements per course were summarized in boxplots separately for the pre-
test, training and examination measurements. The Friedman test was used for 
testing whether the results of the three measurements were statistically different. 
All statistical analyses were performed using SPSS IBM Statistics 22.0 for Windows. 
Results
EQC program
Evolution of the inter-laboratory CVs of sperm concentration, morphology and 
motility assessment is shown in Figure 1. Additionally, the mean values of these 
measurements over time are shown in Figure 2. There was a decreasing trend 
for inter-laboratory CVs of sperm concentration assessment (range=24.0%-97.5% 
in 2001-2004), towards a more stable period in 2015-2018 (range=12,7%-20,9%). 
The variability in mean values had a more or less stable course over the total 
period (range=2.1-59.0). Morphology assessment was characterized by a declining 
trend in the means until 2006, whereafter multiple outliers (with a maximum of 
375.0%) of inter-laboratory CVs were shown in the period 2007-2014. Since 2015, 
the range of inter-laboratory CVs has been stabilized (43.9%-69.6%). Both levels of 
inter-laboratory CV and mean (range= 15.0-95.0) of motility assessment variated 




Results of sperm concentration, morphology and motility assessment during pre-
test, training and examination are summarized in boxplots in Figure 3. In total, 
19 courses were offered between 2008-2018, where 15 participants per course 
evaluated the semen samples. Between pre-test and training measurements, the 
CVs decreased significantly for all parameters (concentration: p=0.00; morphology: 
p= 0.00; motility: p=0.01). For concentration assessment, the initial improvement 
between pre-test (median=41.80) and training measurements (median=23.25) was 
followed by a significant deterioration (p=0.01) between training and examination 
(median=34.95). For both morphology (p<0.01) and motility assessment (p=0.04), 
the CVs significantly decreased from pre-test to examination. Differences between 
training and examination were not statistically different (p=0.64 and p=0.82, 
respectively). 
Discussion  
This study shows that, despite a low level of standardization, the variability in 
semen analysis results decreased in time in the Dutch EQC program, especially for 
concentration measurement. Also, during the Dutch version of the standardized 
BSAC of the ESHRE a positive effect of training on variability was perceived. 
The need of standardization of semen analysis among laboratories was 
emphasized previously (2,31). Also, previous studies showed beneficial effects 
of EQC and training on realizing standardization of used methods and reducing 
variability of semen analysis (19,25,26,27). Despite the long-standing presence 
of the Dutch EQC program and BSACs in the Netherlands the used methods on 
fertility laboratories are still characterized by lack of standardization.4 This study 
showed that even with a lack of standardization, EQC outcome show a reduced 
variability of semen analysis results over time. Interestingly, when we only analyze 
concentration results of laboratories using the Neubauer chamber, reported CVs 
were comparable to the total CVs independent of used counting chamber (results 
not shown). The variability in semen analysis results might, therefore, not only be 
caused by the lack of standardization (i.e. in this case of the counting chamber). 
Training of the standardized method could, therefore, be an important tool to 
further improve BSAC results. 
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Figure 1. Overview of the 
coefficient of variation 
(CV) of the external 
quality control (EQC) 
program results for 
each semen parameter. 
EQC consisted of four 
distributions each year 
with two samples per 
distribution. Each dot 
represents the CV (in 
%) of one EQC sample 
between 2001 and 2018 
(concentration and 
morphology) respectively 




Where other studies showed reduction of variability of all aspects of semen 
analysis during EQC programs (15,16). our study only showed a positive effect on 
sperm concentration assessment. An explanation for the absence of a comparable 
effect for morphology assessment can be found in the instruction of using stricter 
criteria in the successive WHO manuals (7,8,9,10,11). The introduction of this 
criteria might result in some uncertainty among fertility laboratories, leading to an 
increased variability of morphology assessment results (multiple outliers within 
the period 2007-2014). This assumption is supported by the reported decline 
of assessed percentages of morphologically normal spermatozoa caused by 
methodological adaptations based on guidelines (32). As a result of this trend, the 
value of the assessment of morphologically normal spermatozoa in counseling 
individual couples is under discussion in recent literature (32,33,34). 
For sperm motility, inter-laboratory CVs were comparable during the total study 
period. An explanation for this is that the motility assessment was included 
for a shorter period (since 2013) in the EQC program than concentration and 
morphology assessment (both since 2001). It is possible that the effect of EQC 
on the variability of motility assessment did already occur before 2013 and that 
this reduction is, therefore, not visible in the EQC results used in this study. 
Moreover, the CVs of motility assessment (<40%) were already lower than those 
of morphology assessment. Also, motility assessment in the EQC program 
was based on videos instead of microscopic examination, thereby limiting the 
influence of used methods (e.g. counting chamber and pipetting) on variability 
of the measurements. Compared to video assessment, it is known that real time 
microscopic motility determination of cryopreserved semen in EQC programs 
showed high inter-observer and inter-laboratory variability (35). Therefore, as long 
as WHO recommends real time manual motility analyses (7), the actual value of 
EQC video results will be lower than intended (lower commutability). 
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Figure 2. Overview of 
the measured mean 
values of external 
quality control program 
samples for each 
semen parameter. 
Each dot represents 
the mean value of the 
data supplied by all 









Next to EQC, another important requisite is training. BSACs have been offered 
since 1994, where the contents have been updated regularly based on new 
findings and publications (30). During standardized training courses, substantial 
reductions of inter- and intra- observer variability were reported, due to improved 
theoretical and technical skills of the participants (20,21,22,23,24,26). Also in the 
present study, a statistically significant reduction of the variability between pre-
test (baseline measurement) and training was seen for all sperm parameters. For 
concentration assessment, however, this reduction was followed by a significant 
increased variability of examination results, where the variability between pre-
test  and examination results were not statistically different. This finding might 
be explained by the  course contents and the manner the practical examinations 
of the course are set up. During pre-test, participants were asked to perform 
semen analysis using their own equipment and methods. The next day, WHO/
ESHRE recommended methods were taught and trained in order to maximize 
standardization. For the final assessment, one hypothesis is that examination stress 
might influence the results, as well as increased time pressure (all assessments 
need to be performed within a time interval of two hours). Since concentration 
assessment is a complex analysis (36,37), we hypothesize that the impact of stress 
due to time pressure might be especially of influence on concentration results. 
This trend in concentration assessment, however, was not reported in a previous 
study (21). 
Both EQC programs and training can be useful strategies to reduce variability of 
semen analysis and to implement standardization of used methods. It was shown, 
however, that even after introduction of both strategies, used methods for semen 
analysis are still characterized by a wide variability (4). In order to implement 
better standardization, it might be useful to improve both the offered training and 
EQC program. It is for example, important that the reported beneficial short-term 
effects on the variability of concentration, morphology and motility assessment 
caused by semen analysis training is also realized as long-term effects. It has 
already been shown that long-term effects of BSAC were an increased awareness 
of standardization and a change in used procedures towards recommended 
methods (25,27,28). As far as we know, however, the long-term influence of on-
site training on the variability in EQC of sperm parameter assessment has not 
been evaluated before. Short (on-site) refresher courses based on BSAC courses 
and WHO guidelines following regular training programs might be an important 
requisite to realize long-term beneficial effects on variability of semen analysis. In 
this way, a more continuous training program is offered to fertility laboratories. 
The need for such approach is supported by the fact that we received frequent 
requests for (additional) on-site training from the participants of the EQC program. 
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Figure 3. Boxplots of the coefficient of variation (CV) of pre-test, training and examination measurements 
for each parameter, during 4-day ESHRE basic semen analysis courses (19 courses with 15 participants 
each). Pre-test: results on day 1 of the course before any training; training: results during the training 









Next to refresher courses, also the EQC setup can possibly increase awareness of 
variability in relation to standardization. In The Netherlands, the SKML introduced 
a multi sample evaluation system that is based on six sigma. This system indicates 
the performance of the participants by the precision and accuracy of their 
measurements. SKML assigns a performance score (0-2 points) for each semen 
parameter to indicate the agreement of the results compared to the reference 
values (mean values of the total group of participants) (38,39). The provided score 
informs the laboratories whether their results are within the target area. Scores 
of 1 and 2 indicate results of respectively 2 - 4.5 and ≥ 4.5 sigma within the “state 
of art” tolerance intervals. These scores are assigned per distribution and per year 
(multi-sample evaluation) (39). Reporting the EQC results in this manner might 
be more appealing to reduce the variability of semen analysis of the participating 
laboratories. 
Overall, we conclude that reduction of both inter-observer and inter-laboratory 
variability is still an important challenge. Although many attempts were made, 
both by describing recommendations like WHO guidelines, semen analysis is still 
dependent on the willingness of fertility laboratories towards implementation of 
recommended or new methods. Approaches to reduce the lack of standardization 
of used methods did not yet result in the desired effect. Therefore, training, IQC 
and EQC are at the moment the most useful tools to reduce intra- and inter-
laboratory variability of semen analysis. BSAC should be provided as an initial 
training program (21), followed by internal and external quality control programs, 
regular refresher courses and a course management system to maintain 
knowledge and to inform about new findings and publications. A combination of 
video instructions and an e-learning program could be an useful tool in this. 
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The impact of external quality control and standardized training in the 
Netherlands on semen analysis results was described in an earlier study (1). 
Both are requisites to implement standardized methods and to minimize intra- 
and inter-observer variability. The EHSRE Basic Semen Analysis Course (BSAC) 
performed in chapter 5, has been offered since 1994 and the contents have been 
updated regularly based on new findings and publications (2). The standardized 
course was implemented all over the world, in the Netherlands since 1996 (3). 
This standardized training course improved theoretical and technical skills of the 
participants and, consequently, reduced inter- and intra-observer variability (2-6)). 
Chapter 5 did also show statistically significant reduction of the variability for all 
sperm parameters. 
Where immediate effects of training were subject of several studies, long-
term effects of training on variability of semen analysis results have not been 
studied before. However, training did show increased awareness of the need for 
standardization and even significant changes in used methods on the long term 
(3,5,7). Standardization of methods used for semen analysis is essential and it is, 
therefore, valuable to evaluate the impact on semen analysis results as well. 
The working group on semen analysis of the Dutch Foundation for Quality 
Assessment in Medical Laboratories (SKML) received multiple request of Dutch 
fertility laboratories participating in the external quality control for medical 
laboratories for extra semen analysis training. They mainly requested for an 
update of insights in the field, recommendations on sperm parameter assessment 
and on-site training including subjects such as semen analysis and IUI. The goal of 
this chapter was, therefore, to provide short on-site training based on the WHO 
laboratory (8) and ESHRE recommendations and to evaluate its long-term effects 
on semen analysis results in an external quality control (EQC) program.  
Materials and methods
EQC program
In the Netherlands, the Dutch Foundation for Quality Assessment in Medical 
Laboratories (SKML) distributes samples and digital data for the analysis of sperm 
characteristics, including the sperm parameters concentration, percentage of 
morphologically normal spermatozoa and percentage of motile spermatozoa. 
Participants of the regular EQC program are mainly fertility laboratories, clinical 
chemistry laboratories and microbiological laboratories. Since the start of the 
program, about 100 laboratories participate in the EQC program each year. Two 
samples for assessment of concentration, morphology and motility are distributed 
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on a quarterly basis (i.e. March, June, September and December) and should, 
preferably, be evaluated by the technician in charge. Motility assessment was 
included in the program since 2013. 
Since 2015, the results of the SKML participants are reported in the six sigma 
context, indicating their performance by the precision and accuracy of their 
measurements. SKML assigns a performance score (0-2 points) for each semen 
parameter to indicate the agreement of the results compared to the reference 
values (mean values of the total group of participants) (9,10). A score of 0 points 
means that the results are below 2 sigma within the target area. One and two 
point scores indicate results of respectively 2 - 4.5 and ≥ 4.5 sigma within the 
“state of art” tolerance intervals. These scores are assigned per distribution and 
per year (multi-sample evaluation) (10). 
On-site training
In 2015, a total of 106 laboratories participated in the regular EQC program of the 
SKML. All laboratories were invited for on-site semen analysis training. Interested 
laboratories performing all analyses of interest (i.e. concentration, morphology 
and motility assessment) were randomly divided into a training group (n=8) and 
a control group (n=16) without training. The training was given in Dutch language 
and was developed for experienced technicians performing semen analysis. 
Training took approximately 2-4 hours and included fundamental principles of 
semen analysis, as well as information about the EQC program of SKML. The 
content of the training was based on the laboratory manual of the WHO (8) and 
the recommendations provided by the ESHRE SIGA (11). Also, used methods and 
materials of the laboratories were evaluated and, if necessary, suggestions to 
improve these methods were provided. After all training visits took place, a list 
with recommendations based on observations or questions raised during the 
visits was sent to the participants of the training group. 
In order to realize standardization, the laboratories in the training group were 
asked to analyze the post-training measurements by standardized materials and 
methods. Participants were recommended to use a positive displacement pipette 
for sampling and the improved Neubauer haemocytometer for sperm counting. 
For assessment of the percentage morphologically normal spermatozoa, use of 
the May-Grünwald-Giemsa staining (MG Giemsa) (12) was recommended, since 
this was the best available staining method on the visited laboratories. 
To evaluate the impact of on-site training on the accuracy of semen analysis, 
results of the EQC program were used. Since all laboratories in the group were 
visited and trained in January-February 2016, results of the four measurements 
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in 2015 were used as baseline measurements. They were compared to the four 
(post-training) measurements in 2016. 
Statistical analyses
Boxplots and SKML scores (0-2) were used to examine the impact of on-site training 
on semen analysis results. Measurements of each sample were separately shown 
for the groups with and without training. A mixed-effects analysis was performed 
to test if participants of the training group performed sperm assessment with 
less variability after training compared to before the training. Training (yes/no) 
and moment of measurement (before/after training) were evaluated as fixed-
effect covariates and lab number, distribute (1-8) nested in lab and sample (A/B) 
nested in distribute were included as random effects. All statistical analyses were 
performed using SPSS IBM Statistics 22.0 for Windows. 
Results
In total, 8 laboratories were included in the training group and 16 laboratories in 
the group without training. The methods used before and after training for both 
groups were summarized (Table 1). Strikingly, although clear instructions were 
given, training did not result in important shifts in applied methods. The SKML 
performance scores (score 0,1 or 2) did not change significantly: the intervention 
group scored on average 72% (SD: 14) of the maximum achievable score in 2015 
and 78% (SD: 11) in 2016, where the control group scored 68 (SD:21) and 80 
(SD: 17), respectively. Also, boxplots (Fig. 1) show that the agreement between 
laboratories in both groups (training and control) was comparable for sperm 
assessment before (samples 3/’15 – 12/’15) and after (samples 3/’16-12/’16) 
intervention. Moreover, there was no difference in sperm assessment between 
the groups with and without training. Results of the mixed-effects model were in 
accordance with this: sperm parameter results were not influenced significantly by 
participating in the on-site training program (concentration: p= 0.98; morphology: 
p= 0.22; motility: p= 0.21). 
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Table 1. Semen analysis procedures used by the participating laboratories in the intervention (training) 
and control (no training) group during the SKML distributions in 2015 (before intervention) and 2016 
(after intervention). The numbers represent the number of laboratories using a certain technique.


































































*Some laboratories evaluated the motility according to both WHO 1999 and WHO 2010 and/or changed 
their methods over the different measurements.
Discussion
The short-term beneficial effects of standardized training reported in chapter 5, 
seem to be temporary as long-term effects of on-site training on the results of 
EQC could not be measured (Fig. 1). To draw a hard conclusion, however, it is 
important to take the differences in the setup of both training programs into mind. 
BSAC lasts 4 days, the program is interspersed with several breaks, it is offered 
to technicians from different laboratories and their acquired skills were tested 
during examination. In contrast, on-site training was short (up to 4 hours), offered 
to technicians of one laboratory using their own equipment and participants were 
not tested during an exam. 
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Sensemaking is an important process to achieve changes in professional 
environments (12) and could be the most important factor causing the reported 
differences between short-term and long-term training results. Sensemaking is 
about the ways people generate what they interpret and how gathered information 
takes form when people make retrospective sense of this, based on their own 
experiences and consequences of their actions (13). It is an ongoing social activity 
in which individuals respond to the environment they face (14). This process could 
explain the differences in effectiveness of the two trainings offered in our study. 
Where sensemaking is present in BSAC since the training lasts 4 days and includes 
time for social interaction, the short and top-down instruction provided during 
on-site training is missing this aspect. Lack of sensemaking could be responsible 
for unchanged variability after training, but also for the fact that most laboratories 
with training did not change their used methods (Table 1). Although on-site training 
could be useful, the setup should be evaluated and adjusted, taking sensemaking 
into account. Related to this sensemaking theory is the necessity of internal quality 
control (IQC) and in-house training. Once qualified for analytical work according 
to the standards of a center, a technician should participate in ongoing IQC and, if 
necessary, get in-house training. 
Other reasons for the lack of effect of on-site training on long-term results, can 
be found in the selection procedure of participating laboratories, the statistical 
power of the study and geographical limitation. Selection was random, as well 
as the randomization into training and control group. This resulted in more or 
less comparable pre-training results between both groups. Since knowledge and 
experience of the technicians impacts the reliability of semen analysis results (15), 
on-site training might have resulted in a larger effect when offered to laboratories 
with lower baseline results. The statistical power of the study is too low to draw 
proper conclusions based on our findings, also as a consequence of the high 
variations in results. This study can, however, be seen as a pilot for future, more 
extensive research. Geographically, the study is limited to The Netherlands. Earlier 
research showed that many Dutch laboratories are not prepared to work strictly 
according to WHO instructions (16). Because this is not a unique situation (17-19), 
our results can be valuable worldwide. 
Training of fertility technicians is an important tool for reducing variability of 
semen analysis. However, the short on-site training offered in this study was not 
sufficient for realizing long-term beneficial effects. It seems useful to put more 
time and effort in developing a more extensive training program. BSAC could 
be used as initial training (2), followed by quality control programs and multiple 
regular refresher courses. Update of findings and new publications should be 
taken into account. Such approach needs to be subject for further research.
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Figure 1. Coefficient of variance 
for each parameter of two 
different samples assessed before 
training (March, June, September, 
December 2015) and after 
training (March, June, September, 
December 2016), for the training 
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Infertility has a high impact on the quality of life of an affected couple, resulting 
(not exclusively) in social, sexual, psychological and emotional consequences. Also, 
higher rates of depression, nonspecific emotional distress, less life satisfaction 
and happiness, anxiety and even episodic suicidal ideation are reported in 
couples seeking fertility treatment (1). It is, therefore, important to provide an 
adequate infertility diagnosis, to minimize the impact of infertility treatment and 
to optimize the pregnancy results of the offered treatment. One way to realize this 
is optimization of semen analysis and (the technical phase of) IUI.
Semen analysis is an important tool to investigate male fertility and is, therefore, an 
important requisite for selecting the best treatment option offered to an infertile 
couple. IUI is one of the treatment options for infertile couples and is cost-effective 
in selected couples. However, due to lack of evidence-based recommendations 
and lack of standardization for both aspects, improving both techniques is an 
important goal to pursue. Basically, this thesis aimed to provide recommendations 
for fertility clinics to improve semen analysis and IUI for the treatment of couples 
diagnosed with male factor infertility. 
Evolution of IUI
Louise Brown, born in 1978, is known for being the first human conceived after 
using IVF. The story about the first child born after the use of donor insemination, 
however, is less well-known. Professor Pancoast performed, back in 1884, the first 
artificial impregnation of a woman. Without knowledge of the examined infertile 
couple, the professor inseminated fresh semen from the “best-looking” medical 
student, which resulted in the birth of a boy (2). Presumably, it was the start of the 
use of donor insemination. Consequently, the development of artificial insemination 
methods was described for the first time in 1899 (3). Several new techniques have 
been developed and introduced since then, including the sperm preparation, use of 
frozen spermatozoa, follicle stimulation and the timing of ovulation. The popularity 
of artificial insemination, however, increased most after the introduction and 
availability of donor sperm (3). Due to improved sperm selection techniques, IUI 
became the first choice of treatment in selected infertile couples.  
The success of IUI is dependent on several factors, such as female age (4,5), 
duration of infertility (6), stimulation protocol (7), timing of IUI (8) and more. The 
impact of patient characteristics and clinical factors on IUI outcome has been 
studied extensively (9,10). On the other hand, the technical stage of IUI has been 
studied less frequently and is barely included in clinical guidelines. So, where the 
optimization of artificial insemination methods took a run over the years, efforts 
to optimize basic procedures used during IUI treatment more or less stagnated. 




the subjects semen analysis, sperm preparation and quality assurance (11). The 
previous edition of the WHO guideline (1999) was updated in 2010, with major 
changes on sections about cryopreservation of spermatozoa, assessment of semen 
analysis parameters (i.e. sperm numbers, azoospermia, motility and morphology) 
and quality control (11). Updating the current knowledge among procedures 
performed during the technical stage of IUI could result in standardization of used 
methods, but also in improving the effectiveness of IUI treatment. 
Chapter 2 of this thesis summarizes all available literature focusing on the influence 
of procedures related to semen collection (e.g. ejaculatory abstinence, collection 
place), semen processing (e.g. preparation method, buffer of wash medium) and 
insemination (e.g. method of timing, bed rest after IUI) on pregnancy results of IUI. 
Also, the association between pregnancy rates and several time intervals related to 
the IUI treatment and the used equipment were evaluated. This review revealed, 
unfortunately in accordance with the expectations, that it is still hard to come-up 
with evidence-based recommendations in order to develop guidelines for optimal 
IUI treatment. The problem related with these IUI procedures is threefold: 1) for 
some procedures only limited studies were performed and/or well-designed 
retrospective studies are not available 2) available literature is characterized by 
the absence of standardized methods or the inclusion of small study populations, 
3) impact of the procedures on pregnancy results has not been studied yet, only 
the impact on for example sperm parameters or other pregnancy related factors. 
It has already been shown that the willingness to implement guideline 
recommendations in IUI care is far from optimal (12,13), which mainly could be 
explained by missing supporting evidence for the provided recommendations 
(14). Unfortunately, we were also unable to endorse earlier provided findings, 
even after an extensive literature search on this subject (chapter 2). Whether 
the lack of standardization related to this could also be seen in the Netherlands 
was evaluated in chapter 3. An overview of the used methods for both semen 
analysis and laboratory IUI procedures at that moment was provided, based 
on a survey performed at Dutch fertility laboratories. Only a limited number 
of the participating laboratories used the procedures as recommended by the 
WHO guideline (11), which was especially the case for semen analysis methods. 
As a result, a wide variation of used methods was seen. Again, the need of 
standardization of IUI methods was emphasized, also supported by the reported 
influence of the investigated procedures on IUI pregnancy results. Even though 
their impact was analyzed without taking care of any bias or the predictive power 
of reported associations, it indicated that standardizing these methods will help 
optimizing performance of IUI care among IUI clinics. 
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As stated before, used IUI procedures lack standardization and used methods 
remained more or less the same over the last years, mainly as a result of a lack 
of evidence of recommendations in this field. This does, however, not mean that 
the question “techniques used for IUI: is it time for a change?” has never been 
raised before. Several research groups put effort in evaluating specific parts of IUI 
and the impact of used methods on its outcome. However, as long as performed 
studies fail to show clear evidence in favor of new or not yet standardized methods 
compared to the currently used methods, lack of standardization and unwillingness 
to adapt laboratory methods will continue to exist. Based on earlier publications 
of their guideline, the WHO was aware of the fact that some recommendations 
needed sufficient explanation and supporting evidence. In many cases, however, 
they experienced difficulties with endorsing, changing or updating them, due to 
insufficient available data (11). Along with that, our recommendations provided in 
chapter 2 were perhaps not always supported with sufficient evidence, but should 
be considered for other important reasons (i.e. for the purpose of standardization, 
ease, quality control or costs). Even more, the results of our questionnaire study 
(chapter 3) pointed in the same direction of optimal procedures.
Missing evidence-based recommendations is not the only reason that the 
willingness to adapt current procedures is rather low. The value of IUI in infertility 
treatment management is under discussion. For several years, IUI was reported 
as first-line treatment in couples suffering from mild to moderate male factor and 
unexplained infertility (15). IUI is a relatively simple and non-invasive treatment, 
reported as being cost-effective in these specific couples. In 2013, however, the 
NICE published a guideline where expectant management was recommended 
over IUI in couples with unexplained infertility, mild endometriosis or mild 
male factor infertility (16). They stated that these couples should be offered IVF 
after they have attempted to conceive for a total of two years by having regular 
unprotected sexual intercourse. IUI should only be offered as a treatment option 
to couples being unable to have vaginal sexual intercourse, for example due to 
clinically diagnosed physical disability or psychosexual problems, in couples with 
specific conditions (e.g. HIV positive male) or in same-sex relationships (16). 
Even before the NICE guideline was updated, the effectiveness of IUI compared to 
IVF and ICSI success has been discussed extensively (17-20). Around development 
and publication of NICE guidelines, there were even a few studies reporting 
evidence against the use of IUI (21-23). The recommendations of the NICE, 
however, have led to a lot of commotion in the field, with the general conclusion 
that the recommendations on IUI procedures need a radical review (3,24-26). 
Several studies investigated the value of IUI since then and concluded that it 
is still a useful, cost-effective first-line treatment in selected couples, especially 




majority of fertility clinics (96%) in the United Kingdom continued to offer IUI after 
the publication of the NICE recommendations (25,31,32). As a response to the 
provoked debate, the NICE reviewed available evidence on their recommendations 
on IUI treatment. They concluded, however, that there was no reason to adapt 
earlier provided recommendations (33). 
Based on our findings, the conclusions drawn by the NICE seem to be too 
short-sighted. IUI can still be an important requisite in the treatment of couples 
suffering from infertility. Even more, IUI pregnancy results could be improved by 
several factors (i.e. by knowledge expansion and standardization (chapter 2 and 
3)). The low willingness to adapt current protocols is understandable, especially 
when evidence-based recommendations are missing. Discussion regarding 
the effectiveness of the treatment could also clarify why clinics are less willing 
to change their way of working and to put effort in related costs and time. 
Participants of our survey (chapter 3), however, informed us that they recently 
changed or were planning to change parts of performed semen analysis and/or 
IUI as a result of re-organization (e.g. by fusion of laboratories. This should be a 
perfect moment to thoroughly evaluate currently used methods and associated 
potential improvements of it. Nevertheless, they should take into account that the 
use of standardized methods is important for optimizing the performance of care, 
counseling of infertile couples and IUI related pregnancy results. 
It is not only important to provide evidence-based recommendations in available 
guidelines, but also to apply adequate strategies to implement them in clinical 
practice. The difficulties associated with guideline implementation are related 
to personal factors, guideline-related factors and external factors (34,35). Where 
strategies are successful in one setting, they may be less successful in another 
setting with different barriers (35). Implementation strategies are more likely 
successful when the barriers are analyzed in advance and when the performed 
strategy includes different types of interventions and addresses physicians’ 
knowledge and attitudes (34).    
Realizing standardization of IUI
To realize standardization, the main goal of chapters 2 and 3 was to enlarge the 
level of knowledge available for semen analysis and IUI procedures. Another 
way of providing tools for realizing standardization is by an practical approach 
of knowledge gaps that are still present for individual semen analysis and IUI 
related factors. Two examples of these factors were investigated in chapters 4 (i.e. 
sperm parameter assessment), 5 and 6 (i.e. training and quality control). The main 
reason for analyzing those two subjects, was a result of the input of Dutch fertility 
laboratories participating in the program of the Dutch Foundation for Quality 
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Assessment in Medical Laboratories (SKML). The semen section of this nonprofit 
organization for external quality control for medical laboratories received 
during the last couple of years multiple requests for either updated insights and 
recommendations on sperm parameter assessment (most frequently concerning 
assessment of sperm morphology) and the possibilities of on-site training about 
semen analysis and IUI. 
Sperm parameters have been reported to affect pregnancy rates of IUI. Higher 
pregnancy rates were reported for semen assessment with a higher level of total 
motile fraction (4,6,36), larger baseline spermatozoa concentration (37) and higher 
percentage of morphologically normal spermatozoa (36). Since the introduction of 
the strict criteria, however, the value of sperm morphology assessment has been 
subject of discussion. In the Netherlands, only a small majority of laboratories 
still performs sperm morphology assessment during routine semen analysis in 
2016 (chapter 3). During counseling of couples, the validated Hunault model is 
used in Dutch fertility clinics (38,39). Sperm morphology is not included in this 
model, which makes it less relevant to perform assessment of this parameter or to 
perform it accurately. The predictive power of the percentage of morphologically 
normal spermatozoa on IUI pregnancy outcomes has been subject of discussion 
since the use of the strict criteria (33,40-49). About the predictive value of other 
sperm parameters has also been some disagreement, yet less frequently. The total 
progressively motile sperm count (TPMSC) was reported to have discriminative 
value (50), however, only with high specificity for identifying those who are 
unlikely to become pregnant after IUI (51-53). A minimum of 5 million inseminated 
progressively motile spermatozoa (NIPMS) is required for IUI, but the predictive 
value of this parameter is less clear (54,55). 
The predictive value of percentage morphologically normal spermatozoa, TPMSC 
and NIPMS for IUI ongoing pregnancy was evaluated in couples visiting the fertility 
clinic of the Radboud University Medical Centre (chapter 4). In predicting the 
pregnancy chance after the first IUI cycle, none of the sperm parameters turned 
out to be of value (i.e. only female and male age). On the other hand, a percentage 
of morphologically normal spermatozoa <4% and a NIPMS between 5-10 million 
were found with a higher probability to become pregnant after first IUI episode. In 
combination with other known predictors of pregnancy, only sperm morphology 
remained of importance. Even though the predictive power of the included sperm 
parameters was rather low, we concluded that both performing semen analysis 
and offering IUI to couples suffering from moderate male factor infertility should 
still be considered as relevant (i.e. sperm morphology ≤4%, NIPMS 5-10 million). 
The value of morphology as parameter to predict IUI pregnancy outcome was by 




parameters, but it does not mean that the evaluation of sperm morphology would 
be of none value. Problems related to morphology assessment are the subjectivity 
of the measurement, lack of compliance towards WHO standards and the low 
reference value of 4% morphologically normal spermatozoa. The introduction 
of this reference value was based on the definition for morphological normal 
spermatozoa based on spermatozoa obtained from the level of the internal cervix 
after penetration through cervical mucus (56). However, when classification was 
doubtful, the spermatozoa should be classified as abnormal (57). The use of strict 
criteria has been criticized for several reasons (58). One of them was that the 
majority of motile spermatozoa are incapable of binding to the zona pellucida, 
which indicates that male subfertility is related to a reduced number of capable 
sperm instead of reduced capability in all sperm (59). Also, a morphologically 
“normal” looking spermatozoon does not necessary have the ability to fertilize 
an oocyte, if capacitation or the acrosome reaction does not occur (60). However, 
abnormal morphology results should be an indication to evaluate the health 
of the male partner (e.g. by testicular ultrasound or endocrine examination). 
Moreover, specific morphologically abnormalities, such as globozoospermia or 
stress-induced elongated sperm heads, will be missed during sperm morphology 
assessment. While these abnormalities are rare, ignorance does have impact on 
adequacy of patient selection for fertility treatment (57). 
Studies performed after publication of chapter 4 reported better pregnancy 
results in the group with normal sperm morphology and higher progressive 
motility of the spermatozoa (61,62), but also no impact of TPMSC on IUI pregnancy 
rate (152). Also, a review concluded that sperm morphology did not affect IUI 
pregnancy outcome (154). Concerning the NIPMS, results suggested importance 
as predictor of IUI pregnancy. Nevertheless, NIPMS is not assessed during initial 
fertility workup and would therefore only be useful determining whether a couple 
should move over to another fertility treatment option once IUI has already been 
started (55). An already known pitfall related to fertility studies is also applicable 
for studies evaluating predictive power of sperm parameter assessment: lack of 
standardization in study designs, in methods used to perform semen analysis, 
in included study patients and in policy regarding other predictive factors (50). 
This could not only be the explanation for reported conflicting results, but also 
in an overall over- or underestimation of the predictive value of (one of) these 
parameters. Overall, we showed the importance of assessing values of sperm 
parameters during semen analysis, since they provide useful information for 
counseling of male factor infertility. Combining the values of all parameters could 
also provide clinically meaningful classification into fertile, indeterminate and 
subfertile (65). However, also in this classification system overlap was reported, 
probably due to female factors contributing to the infertility of the couple (65). 
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CHAPTER 7
Where chapter 4 was set up to contribute to knowledge enrichment regarding 
parameters assessed during semen analysis, it is important that this information 
should reach the designated persons. Training of laboratory personnel is one 
important requisite to reach this goal. Also, it is a useful strategy to implement 
standardized methods and to reduce variability of semen assessment results 
caused by the subjectivity of the assessment (66). Intra- and inter-observer 
variability and inter-laboratory variability have impact on the reliability of 
counseling male factor infertility and, consequently, on the adequacy of treatment 
selection (67). Reducing variability of all aspects of semen analysis could already 
been reached by training of laboratory technicians within only a few days (67-72). 
On the long-term, most important consequences of training were laboratories 
changing their methodologies and trying to reach standardization (73-75). These 
studies, however, were already performed over twenty years ago, long before the 
last update of the WHO laboratory manual.
The training program (basic semen analysis courses (BSAC) organized by the 
European Society of Human Reproduction and Embryology (ESHRE)) was 
standardized and implemented in several countries throughout the world (69). 
Since 1996, the course has also been offered in the Netherlands (75). During 
this training, a theoretical background and extensive practical training regarding 
semen analysis is given. Semen parameters were assessed at three moments 
during the training program (pre-test, during training and examination). We found 
in chapter 5 that a reduction of the variability of measurements was, in particular, 
seen between pre-test and training measurements. This trend was not continued 
in the same manner towards examination, probably caused by examination stress 
and the way examination was performed. On-site training, based on the BSAC 
courses, was offered to Dutch laboratories as additional training moment (chapter 
6). The impact of this training moment was evaluated during four measurements 
over time between laboratories with and without training. There was no significant 
influence of training on the variability reported for any of the assessed semen 
parameters. Also, the training program did not result in standardization of used 
methods in the training group. The absence of long-term effects, however, could 
also be related to the design of performed training program. Reasons for the lack 
of long-term effects of on-site training might be found in lack of standardized 
procedures of participating laboratories, low statistical power to the small sample 
size, too concise contents of the course or lack of sensemaking introduced in the 
course. Sensemaking is important, since it influences the way of interpretation of 
the course contents (76) and it determines the way participants will respond to it 
(77). Laboratories will have more willingness to change their used methods, when 




The implementation of an external quality control (EQC) program is another 
approach to measure intra- and inter-laboratory variability and may, consequently, 
reduce practice variation. Next to reducing inter-laboratory variability over time 
(78,79), it caused also a reduction of inter-observer and intra-laboratory variability 
(80,81). Together with appropriate training of personnel, internal and EQC programs 
should, therefore, be considered as standard policy on fertility laboratories. This 
statement is supported by our findings for evaluating results over time (2001-
2018) of the Dutch EQC program in chapter 5. Especially for inter-laboratory 
variability of sperm concentration, the reduction over time was important. On the 
other hand, such decline could not be found for morphology assessment. This 
was most probably caused by methodological changes performed in this period.
In general, semen analysis methods did hardly change over the years. Comparing 
methods recommended in the current WHO guideline (11) with those provided 
in the first version of the guideline (published in 1980) (82) demonstrates that 
the majority of the recommendations remained the same. Where automation was 
implemented in clinical chemistry and microbiology, this is not the case for semen 
analysis. There were only a few attempts to introduce automated procedures in 
this field. Using automated procedures, however, eliminates variability caused 
by manual assessment and it is therefore valuable to develop or improve 
such procedures (83,84). Future studies could for example focus on computer 
assisted semen analysis (CASA). It was introduced in the early 1990s and has still 
disadvantages with respect to manual analysis, in terms of precision, accuracy, 
know-how of the technician and analysis time (85). As a result, large groups of 
experts share the opinion that manual analysis should be preferred and strict 
standards must be set before the implementation of CASA (86). Others believe in 
the benefits of using CASA when further evaluation is performed for morphology 
assessment (87) or parameters other than routinely performed according to the 
WHO are measured, like principal piece analysis (85,88,89). Before CASA could 
be implemented in routine semen analysis, more research is needed. Another 
automated procedure valuable as subject for future studies is microfluidic 
spermatozoa selection. Microfluidic technologies could be used for the analysis 
and separation of sperm cells (90-92). Next to potential value for diagnostics, it was 
shown that these technologies could be used to separate boar spermatozoa from 
erythrocytes (93). This can be useful for ICSI procedures, in cases where sperm 
has to be extracted from testicular biopsies or epididymal aspirations. However, 
before this chip can be validated and, consequently, be used in the clinic, further 




Recommendations for the fertility clinic
The main goal of this thesis was to provide recommendations on semen 
analysis and IUI related laboratory procedures, to optimize diagnosing infertility, 
counseling of the couples and treatment success. We showed, despite several 
uncertainties and difficulties, numerous points for improvement. Standardization 
of used procedures is the major factor of these. At the moment, realizing short-
term standardization of semen analysis and IUI treatment is an unrealistic 
ambition. Providing tools for realizing a step-by-step approach is the best we 
can do. Also, since the willingness to implement recommendations provided in 
IUI guidelines is rather low (12,13), it is important to pay attention to selecting 
adequate implementation strategies. Therefore, the potential clinical areas for 
clinical effectiveness activities, the likely benefits and costs required to introduce 
guidelines and the likely benefits and costs as a result of any changes in provider 
behavior need to be considered (94). Recommendations based on theory-based 
research should provide citations to original literature related to theory-based 
research, as well as methodological details regarding the way recommendations 
have been operationalized and analyzed (95).  
Interestingly, a lot is still unknown, even though IUI has been performed for a long 
time. Technical aspects of semen analysis and IUI with missing evidence or a low 
level of evidence are not exceptional. Where literature is scarce, findings of each 
new study can have significant impact on earlier provided recommendations. 
Preferably, large standardized RCTs should be performed evaluating the impact of 
IUI-related factors on IUI outcome. Once these new studies will result in updated 
recommendations, it is important to pay special attention to implementation of 
this on IUI laboratories. If laboratories are already willing to adapt their laboratory 
procedures, we would recommend them to sustain an ejaculatory abstinence of 
up to 3 days (96,97), avoid long time intervals between semen production and 
processing (98) and use zwitterion-buffered media (99). These methods were 
found as best practice in both our literature review (chapter 2) and questionnaire 
study (chapter 3). 
Among the semen parameters assessed during semen analysis, most useful 
improvement could be reached for morphology assessment. As shown, the 
reliability of the assessment might be improved by using an easier staining method, 
better and more meaningful agreements in defining normal and abnormal 
spermatozoa or improving computer assisted semen analysis. For now, it is still 
useful to assess sperm concentration, morphology and motility during semen 
analysis and use the results during counseling of the infertile couple. In couples 
suffering from male factor infertility, IUI should especially be performed in couples 
categorized as mild to moderate. The value of IUI for couples with unexplained 




Important requisites to reduce practice variation and variability of semen analysis 
results are quality control programs and training of the laboratory technicians. It 
might be useful to take sensemaking into account during development of training 
programs. Also, the BSAC of ESHRE should be used as guideline for background 
theory. After initial training, knowledge levels should be maintained, for example 
by internal and EQC programs, refresher courses or video instructions. It is also 
important that findings of EQC programs are reported to participants, providing 
information on performance of the individual semen assessment results over 
time, as well as compared to other laboratories. 
Preferably, laboratory specific programs are developed combining implementation 
strategies of provided (evidence-based) recommendations, step-by-step realization 
of standardization, quality control programs (both internal and external) and 
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Approximately 15% of the reproductive couples suffer from infertility, of which 
about 50% is due to male factor infertility. The development of spermatozoa 
during spermatogenesis and, eventually, the fertilization of an oocyte are 
complex processes. Several factors can affect these processes, causing defects 
in the production or transport of spermatozoa. During semen analysis sperm 
concentration, morphology and motility are assessed, which provides useful 
information for the evaluation of male fertility. Moreover, this information is 
relevant for selecting the correct treatment option for couples affected by male 
factor infertility. Intrauterine insemination (IUI) is one of these treatment options 
and is recommended as first-line therapy in couples with mild to moderate male 
factor infertility. Both semen analysis and IUI are performed on a large scale, 
however, there are also shortcomings related to them. 
This thesis describes the studies that we have performed in order to provide tools 
and recommendations to infertility clinics to improve laboratory aspects of semen 
analysis and IUI results in couples with male factor infertility. 
One of the shortcomings of both semen analysis and IUI is the lack of standardization 
of used methods. In order to improve standardization, it is important to increase 
knowledge on the subject and to provide evidence-based recommendations. As a 
starting point, Chapter 2 examines the impact of the procedures and equipment 
used during semen collection, semen processing and insemination on pregnancy 
rates of IUI. The available literature was reviewed and findings were compared 
with the laboratory manual of the World Health Organization (WHO). For several 
procedures, the level of evidence of the provided recommendations was rather 
low or the recommendations were characterized by insufficient supportive 
literature. Even though evidence is poor, some recommendations were provided 
other than the recommendations provided by the WHO. Furthermore, we showed 
that there are opportunities for future research to provide better evidence-based 
recommendations.
Where chapter 2 provides an overview of the available literature, we evaluated in 
Chapter 3 the laboratory procedures used during IUI in Dutch fertility laboratories 
and the impact of these procedures on the pregnancy results of IUI. A questionnaire 
was developed to obtain information on methods used during both semen 
analysis and IUI and requested ongoing pregnancy results of IUI. About hundred 
Dutch fertility laboratories were invited to participate, 49 of them completed 
the questionnaire. It turned out that the lack of standardization reported in 
previous studies, was also seen in the Netherlands, especially for methods used 
during semen analysis. Specific laboratory IUI methods were reported to have a 




best practice findings reported in chapter 2, i.e. semen collection place, semen 
preparation technique and method of timing IUI. The discriminatory accuracy of 
the multivariable model was low (AUC 0.54). Using cycle specific data would be 
more accurate, however, the findings confirmed again the need of standardization. 
Next to standardization of semen analysis and IUI procedures, it is also of 
importance that correct counselling of infertile couples takes place. The value of 
sperm parameters in predicting IUI success is in this matter a useful requisite. 
Chapter 4 describes the predictive power of sperm morphology and the total 
progressively motile sperm count (TPMSC) (assessed during fertility workup) 
and the number of inseminated progressively motile spermatozoa (NIPMS) 
(assessed at the time of IUI) for the probability of achieving a pregnancy after 
IUI. A retrospective, observational study including all couples who visited the 
fertility laboratory of the Radboudumc for a finished IUI episode was conducted. 
For predicting the pregnancy chance after a first finished IUI episode, a positive 
relationship was found for ≤4% of morphologically normal spermatozoa (OR 1.39) 
and NIPMS of 5-10 million (OR 1.73). When other factors were taken into account 
as well (such as female age, male age, number of cycles in the episode), only 
sperm morphology and NIPMS remained significant predictors. This model had a 
discriminatory accuracy of 0.73 and indicates that IUI is especially of relevance in 
couples with moderate male factor infertility.  
Another point of improvement in the accuracy of standard semen analysis results 
is reducing the high levels of intra-and inter-laboratory variability. Strategies 
to reduce variability and the lack of standardization are the implementation 
of external quality control programs (EQC) and the training of technicians 
performing the standard semen analysis. Chapter 5 describes the impact of both 
EQC and training over time on the variability of semen analysis results of Dutch 
laboratories. All participants of the Dutch EQC program analysed 144 semen 
samples for sperm concentration and morphology (2001-2018) and 48 samples 
for motility assessment (2013-2018). A decreasing trend for inter-laboratory 
coefficients of variation (CVs) was shown for sperm concentration assessment in 
the total period (24.0-97.5% in 2001-2004 towards 12.7-20.9% in 2015-2018), but 
such a trend was not found for morphology and motility assessments. Also, we 
evaluated the short-term effects of training using the results of 19 basic semen 
analysis courses offered in the period 2008-2018. For all semen parameters, CVs 
decreased significantly from pre-test to training measurements (p<0.05). The CVs 
of the examination measurements were also significantly lower than pre-test 
measurements for morphology (p<0.01) and motility (p=0.04) assessments. 
Positive immediate effects of training were not only reported in chapter 5, but also 
in other studies. The long-term impact of training of technicians on the variability of 
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semen analysis results, however, was not studied before. Chapter 6 describes the 
impact of long-term effects on semen analysis results in the Dutch EQC program, 
by offering an on-site training based on recommendations provided by the WHO 
and ESHRE. This on-site training was developed, since Dutch fertility laboratories 
reported the need for additional semen analysis training opportunities. We 
compared the results of four pre-training measurements (assessed in 2015) with 
four post-training measurements (assessed in 2016). There were no statistically 
significant differences between semen analysis results of the 8 laboratories 
included in the intervention group compared to the laboratories without training. 
Also, the performance score assigned by the EQC program was comparable 
between both groups: 72% (intervention group) vs. 78% (control group) of the 
maximum achievable score. 
In Chapter 7, we discuss the main findings of our studies. We showed that the lack 
of standardization related to semen analysis and the technical phase of IUI is still a 
major problem. More evidence-based recommendations, together with adequate 
implementation strategies are needed to improve guideline implementation. Also, 
the subjectivity of the analysis of semen parameters is a factor of concern. The 
reliability of the semen parameter assessment should be improved, in order to 
select the best treatment option for infertile couples. Useful strategies are EQC 
programs and training of technicians, since they result in reduced variability of 
semen analysis results. Based on the findings in this thesis, the development 
of laboratory specific programs is recommended, including implementation 
strategies, evidence-based recommendations, quality control programs and 





Ongeveer 15% van de koppels heeft te maken met verminderde vruchtbaarheid, 
zo’n 50% daarvan wordt veroorzaakt door een mannelijke factor. De ontwikkeling 
van zaadcellen vindt tijdens spermatogenese plaats en is net als de bevruchting 
van de eicel een complex proces. Er zijn verscheidene factoren die het kunnen 
verstoren, waardoor er een defect kan ontstaan bij de productie en/of het 
transport van de zaadcellen. Tijdens de standaard semenanalyse  worden de 
concentratie, morfologie en motiliteit van de zaadcellen bepaald. Dit levert 
belangrijke informatie op om de mannelijke vruchtbaarheid te kunnen bepalen. 
Deze informatie is ook belangrijk bij de keuze van de vruchtbaarheidsbehandeling 
voor een koppel met vruchtbaarheidsproblemen. Intra-uteriene inseminatie (IUI) is 
een van die behandelmogelijkheden en wordt aangeraden als eerstelijnstherapie 
voor koppels met een milde tot matige mannelijke factor. Er zijn verscheidene 
gebreken bekend van de standaard semenanalyse en IUI, ondanks dat beide op 
grote schaal worden uitgevoerd. 
In dit proefschrift worden de onderzoeken beschreven die we hebben uitgevoerd 
om handvatten en aanbevelingen aan vruchtbaarheidsklinieken te bieden, om op 
die manier vanuit laboratorium perspectief de resultaten van semenanalyse en 
IUI bij koppels met een mannelijke factor te verbeteren. 
Het gebrek aan standaardisatie is een groot probleem bij zowel semenanalyse als IUI. 
Om dit te verbeteren, is het belangrijk dat er voldoende kennis beschikbaar is en dat 
aanbevelingen gebaseerd zijn op feiten. Daarom werd er in Hoofdstuk 2 onderzocht 
wat de invloed is op de zwangerschapskans van IUI van het gebruik van bepaalde 
procedures en apparatuur gebruikt tijdens de collectie, verwerking en inseminatie 
van zaad. Daartoe is de beschikbare literatuur beoordeeld en werden de bevindingen 
naast de laboratorium handleiding van de Wereldgezondheidsorganisatie (WHO) 
gelegd. Er waren verschillende procedures met een laag level of evidence voor de 
geleverde aanbevelingen of deze werden amper bevestigd in de gevonden literatuur. 
Toch gaven we een aantal aanbevelingen die anders waren dan beschreven door de 
WHO in hun laboratorium handleiding. Ook werden er een aantal punten benoemd 
die in toekomstig onderzoek bekeken kunnen worden om tot betere aanbevelingen 
te komen. 
In Hoofdstuk 3 werd bekeken welke laboratorium procedures er gebruikt worden 
in Nederlandse fertiliteitslaboratoria. Ook onderzochten we wat de invloed van deze 
factoren was op de zwangerschapskans bij IUI. Er werd een vragenlijst ontwikkeld 
waarin informatie werd opgevraagd over de methodes die de laboratoria gebruikten 
bij semenanalyse en IUI. Ongeveer 100 fertiliteitslaboratoria werden uitgenodigd 
om de vragenlijst in te vullen, 49 daarvan vulden de vragenlijst volledig in. Ook 
in Nederland was er sprake van een gebrek aan standaardisatie, met name voor 
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de methodes gebruikt bij semenanalyse. Voor sommige IUI methodes werd een 
significante invloed op de zwangerschapskans gevonden, overeenkomend met 
de resultaten gevonden in hoofdstuk 2, namelijk de plaats waar het zaad werd 
verzameld, de zaad opwerk methode en de methode waarmee IUI getimed wordt. 
De nauwkeurigheid van het multivariabele model was laag (AUC van 0.54). Wanneer 
data specifiek per cyclus bekeken zouden worden, zou dit meer accurate resultaten 
opleveren. Toch werd opnieuw bevestigd dat standaardisatie belangrijk is.
Niet alleen standaardisatie van semenanalyse en IUI is belangrijk, maar ook dat 
de counseling van koppels met vruchtbaarheidsproblemen juist is. Het is daarom 
belangrijk dat de zaad parameters die tijdens semenanalyse bepaald worden 
een goede voorspellende waarde hebben om IUI succes te kunnen bepalen. 
Hoofdstuk 4 beschrijft daarom de gevonden voorspellende waarde van de 
gemeten concentratie, morfologie en motiliteit van het zaad. De morfologie en het 
totale aantal progressief motiele spermatozoa (TPMSC) werden bepaald tijdens 
het fertiliteitsonderzoek en het totale aantal geïnsemineerde progressief motiele 
spermatozoa (NIPMS) werd bepaald op het moment van IUI. In deze retrospectieve 
studie werden alle afgeronde IUI episodes meegenomen die waren uitgevoerd in 
het Radboudumc. Een waarde van ≤4% morfologisch normale zaadcellen (OR1.39) 
en een NIPMS van 5-10 miljoen (OR 1.73) bleken een positieve relatie te hebben 
met de kans op een zwangerschap na een eerste afgeronde IUI episode. Wanneer 
andere factoren, zoals de leeftijd van de vrouw en man en het aantal cycli in de 
episode, ook werden meegenomen, bleven de morfologie en NIPMS significant 
voorspellende factoren. Dit model had een AUC van 0.73, wat aangeeft dat IUI 
vooral bruikbaar is voor koppels met een milde tot matige mannelijke factor.
Een ander verbeterpunt voor de standaard semenanalyse procedure is het 
verminderen van de gerelateerde intra- en inter-laboratorium variabiliteit. Om 
deze variabiliteit te verminderen en de standaardisatie te verbeteren, kan een 
extern kwaliteitscontrole (EQC) programma worden ingevoerd of training van het 
laboratoriumpersoneel plaatsvinden. Hoofdstuk 5 beschrijft de invloed van een 
EQC programma en van training op de variabiliteit van semenanalyse resultaten 
van Nederlandse laboratoria. De deelnemers van het Nederlandse EQC programma 
beoordeelden van 144 zaadmonsters de concentratie en morfologie (2001-
2018) en van 48 zaadmonsters de motiliteit (2013-2018). De inter-laboratorium 
variatiecoëfficiënt (CV) nam langzaam over de tijd af voor de concentratie bepalingen 
(van 24.0-97.5% in 2001-2004 naar 12.7-20.9% in 2015-2018). Dit was niet het geval 
bij de bepalingen van morfologie en motiliteit. Ook werd het korte termijneffect van 
training geëvalueerd, op basis van 19 semenanalyse trainingen aangeboden in de 
periode 2008-2018. De CVs namen significant af voor alle parameters tussen pre-
test en training bepalingen en voor de morfologie (p<0.01) en motiliteit (p=0.04) ook 




De positieve korte termijneffecten van training werden in hoofdstuk 5 en in 
andere studies beschreven. Het lange termijneffect van training werd echter nog 
niet eerder beschreven. Daarom wordt in Hoofdstuk 6 beschreven wat de invloed 
van een training op locatie op de lange termijn was. Er werd een korte training 
ontwikkeld op basis van de WHO en ESHRE aanbevelingen en aangeboden aan 
de deelnemers van het Nederlandse EQC programma. Deze training werd onder 
andere ontwikkeld naar aanleiding van de vraag van deelnemers voor extra 
semenanalyse training. De resultaten van vier pre-training metingen in 2015 
werden vergeleken met vier post-training metingen in 2016. We vonden geen 
statistisch significante verschillen tussen de resultaten van de 8 laboratoria met 
training ten opzichte van de 16 laboratoria in de controlegroep. Ook de score die 
tijdens het EQC programma aan de deelnemers wordt gerapporteerd was niet 
verschillend tussen de twee groepen: 72% van de maximaal te behalen score bij 
de interventie groep versus 78% bij de controlegroep.  
In Hoofdstuk 7 bespreken we de hoofdresultaten van onze studies. We lieten 
zien dat het gebrek aan standaardisatie bij semenanalyse en IUI nog steeds een 
groot probleem is. Er zijn meer aanbevelingen op basis van feiten en adequate 
implementatie strategieën nodig om de implementatie van handleidingen te 
realiseren. Een anders aandachtspunt is de subjectiviteit van semenanalyse. Het 
is belangrijk dat de betrouwbaarheid van de semenanalyse resultaten verbetert, 
zodat de beste behandelmethode voor het koppel met vruchtbaarheidsproblemen 
geselecteerd kan worden. EQC programma’s en training van het 
laboratoriumpersoneel zijn hiertoe belangrijke strategieën, aangezien ze zorgen 
voor een afname van de variabiliteit van semenanalyse resultaten. Tot slot valt 
aan te bevelen om een laboratorium specifiek programma te ontwikkelen, waarbij 
implementatie strategieën, evidence-based aanbevelingen, kwaliteitscontrole 
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Toen ik in 2014 een half jaar stage liep in Zweden vroeg een relatief onbekende 
collega aan me of ik niet nog een echte droom had. Mijn antwoord was: het 
schrijven van een boek. Dat dit in de vorm van een proefschrift zou zijn, had ik 
destijds niet bedacht.
Het realiseren van dit proefschrift zou nooit gelukt zijn zonder de hulp en steun 
van velen. 
Prof. Dr. D.D.M. Braat, beste Didi, jij bent echt een powervrouw met het hart op de 
goede plek! Je wist me bijna altijd wel weer te motiveren dankzij je optimisme en 
enthousiasme. Bedankt voor je fijne begeleiding, maar ook de goede input tijdens 
de besprekingen. 
Dr. A.M.M. Wetzels, beste (grote) Alex, zonder jou zou dit proefschrift er nooit zijn 
geweest. Je hebt je er echt hard voor gemaakt om dit voor elkaar te krijgen. In 
eerste instantie door alle moeite om een langere aanstelling voor me te regelen, 
later alle mailtjes en berichtjes om het een beetje op gang te houden. Het was zelfs 
geen probleem voor je om afspraken buiten werktijd te plannen. Je deed al die 
moeite, ondanks dat ik het je zeker niet altijd makkelijk heb gemaakt. Bedankt dat 
je (bijna) al die tijd er in bent blijven geloven, je tomeloze inzet, opbeurende humor 
en grote bijdrage aan alle artikelen. 
Dr. W.L.D.M. Nelen, beste Willianne, bij jou is het indirect allemaal begonnen 
toen ik mijn masterstage bij jou liep. Wat fijn dat je later ook betrokken raakte 
bij dit promotietraject, je kwam op een gegeven moment zelfs speciaal voor de 
besprekingen naar Nijmegen. Ik heb gedurende die tijd meer van je geleerd dan 
je waarschijnlijk doorhebt. Bedankt voor je bruikbare input bij het schrijven van 
alle stukken. 
Beste medewerkers van het fertiliteitslab, het is alweer een tijdje geleden dat ik 
bij jullie rondliep, maar ik ben jullie zeker nog niet vergeten. Jullie hebben ervoor 
gezorgd dat ik als net afgestudeerde, verlegen onderzoeker langzaam uit mijn 
schulp kroop. Ondanks dat ik niet zoals jullie op het lab werkte, betrokken jullie 
me er toch zoveel mogelijk bij en heb ik me altijd welkom gevoeld. Bedankt voor 
de gezelligheid. 
Beste oud-onderzoekers in de onderzoekstuin, ook al was ik er niet ontzettend 
lang en ook niet heel vaak, toch voelde ik me tussen jullie op mijn plek. Er werd 
serieus gewerkt, maar er was ook genoeg afleiding, met als hoogtepunt natuurlijk 
de onderzoekersweekenden in thema. Bedankt voor alle leuke momenten. 
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Dank aan de leden van de promotiecommissie: prof. dr. F.C.G.J. Sweep, prof. dr. D. 
de Neubourg, dr. ir. E.G.J.M. Arts, prof. dr. M.H.M. Thelen, prof. dr. A.W. Nap, dr. L.I. 
Segerink en dr. S. Sanders-Kos, voor het lezen van het proefschrift en het vervullen 
van hun rol als opponent tijdens de verdediging.
Bedankt aan alle coauteurs voor hun bijdrage aan (een van) de artikelen. Dank 
ook aan iedereen die op welke manier dan ook input heeft geleverd aan een van 
de artikelen of aan dit proefschrift. Het is alweer een tijdje geleden en ik ben bang 
dat wanneer ik iedereen bij naam zou nemen, ik een aantal belangrijke namen zal 
vergeten. 
Oud-collega’s van Elrohe, wat hebben we een goede tijd gehad samen. Bedankt dat 
jullie mij meteen zo goed opnamen binnen het knusse team. Ik ben geen enkele 
dag met tegenzin naar Vierlingsbeek afgereisd (behalve die keer op de fiets). 
Nog steeds mis ik af en toe de gezelligheid, de extra lange 30-seconds pauzes, 
de vrijdagmiddagsnacks en de lachbuien. Ludo, Ruth en Sanne, bedankt voor de 
middagen waarbij die goede sfeer van toen steeds meteen weer terug komt.
Ernst en Ron, bedankt dat ik dit traject mocht afronden naast mijn werkzaamheden 
voor PHARMO en natuurlijk bedankt voor alle dolletjes. Alle collega’s van PHARMO, 
bedankt voor de fijne werksfeer. Jullie zorgen ervoor dat het aanvoelt alsof ik al 
jaren in het team zit. Ik heb jullie interesse in mijn promotie erg gewaardeerd, net 
zoals jullie enthousiaste reactie op mijn baksels (erg welkome afleiding). Ik kijk er 
enorm naar uit om jullie weer dagelijks op kantoor te zien. Jelle, jij bent echt mijn 
maatje geworden in de tijd dat we een werkkamer deelden. Jammer dat je nu 
ergens anders werkt, maar gelukkig klopte wat je vlak voor je afscheid zei: het is 
niet uit het oog, uit het hart.
Femke, Kirsten, Marieke en Muriel, wat leuk dat we elkaar sinds onze gezamenlijk 
Middelbare School tijd nog steeds zien. Ook al wonen we verspreid over het land, 
we doen allemaal moeite elkaar toch te blijven zien. Bedankt voor alle gezelligheid 
en de leuke weekendjes weg.
Lieve (oud-)Akrissers, al tijdens mijn studententijd werd ik lid van Akris en dat 
ik nu nog steeds lid ben, geeft wel aan hoe goed ik me op mijn gemak voel bij 
jullie. Het gaat allang niet meer alleen om tafeltennis, daarmee zou ik de vele 
avondjes stappen, knotsgekke activiteiten, Akrisweekenden, Corona weerwolven 
en de fijne samenwerking in alle commissies (en nog veel meer) tekort doen. Het 
is onmogelijk om iedereen apart bij naam te noemen, zoveel leuke mensen heb 
ik leren kennen. ‘Zuiplui’, bedankt dat oma nog steeds overal aan mee mag doen 
en jullie mij als een echte student laten voelen. Frederick, Maurice, Mianne, Stijn 




het door corona even stil, maar hopelijk kunnen we snel weer onze toffe oud-
bestuursuitjes hervatten. Jorien en Mandy, we hebben vaak bij elkaar in het team 
gezeten, telkens in afwisselende samenstelling. Toch zullen wij altijd, samen met 
Mariska, team 1 blijven. Laten we dat vooral in stand houden met onze uitjes. 
Mariska, jij verdient natuurlijk een aparte vermelding. Nadat we ons eerder al 
bestuursgenoten, teamgenoten en commissiegenoten noemden, mogen we ons 
nu zeker ook goede vrienden noemen. Of zoals anderen zouden zeggen: Jut en Jul. 
Bedankt voor alle toffe dingen die we samen doen.
Chris, toen we nog ganggenoten waren, konden we ons soms gedragen als een 
getrouwd stel. We zien elkaar eigenlijk te weinig sinds jij in Berlijn woont, maar 
wanneer het wel weer zo ver is, is het meteen als vanouds. 
Carola, we hebben elkaar al op verschillende plekken opgezocht: Nijmegen, 
Steenbergen, Londen, Malmö, Gent en altijd was het reuze gezellig. Bedankt 
voor al onze leuke belevenissen. Fariza, we leerden elkaar kennen tijdens een 
snijzaalpracticum, toen bleek dat we dezelfde humor hebben. Dat was voldoende 
voor een mooie vriendschap, want we slenteren nog steeds samen door Nijmegen, 
lachen ons rot om elkaars grapjes en kunnen uren achter elkaar spelletjes spelen. 
Hanneke, het begon allemaal tijdens onze stage, waarbij de onderzoekers van 
andere kamers aan ons vroegen of het bij ons altijd vrijdagmiddag was. Bedankt 
voor alle middagen en avonden waarbij we onze gezamenlijke hobby uitvoeren 
(bordspellen) en we zo hartelijk ontvangen worden door jou, Johannes en de kids. 
Minet, we hebben helemaal niet zo lang samen met elkaar op de opleiding gezeten, 
maar het klikte direct. Ook toen jij in Rotterdam en Breda (en ik even in Zweden) 
woonde, wisten we elkaar te vinden (behalve die keer van het Kronenburgerpark) 
voor toffe uitstapjes. Extra fijn dat je nu in Nijmegen woont en we elkaar nog vaker 
kunnen zien.
Ilse, Renske en Anne, na het afgelopen jaar zijn we bijna professionals in online 
meeten en activiteiten ondernemen. Het wordt tijd dat alles weer mag: samen de 
4Daagse feesten onveilig maken, uit eten, oud & nieuw vieren (met champagnepong!) 
of gewoon weer lekker op stap. Ons weekendje Schiermonnikoog, vlak voordat 
de maatregelen weer werden verscherpt, vond ik een van de hoogtepunten van 
2020. Terecht dus dat we ons hebben voorgenomen er een jaarlijks weekendje 
weg van te maken. 
Lieve Gisella en Janou, dat jullie mijn paranimfen zouden worden, was geen 
moeilijke keuze. Nadat jullie je taak als mijn getuigen met zoveel verve hebben 
vervuld, was het tijd voor een nieuwe uitdaging. Wat kan ik me gelukkig prijzen 
met vriendinnen als jullie. Aan onze vriendschap (en onze belevenissen) zou ik 
met gemak een apart boek kunnen wijden, daar is hier helaas geen ruimte voor. 
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CHAPTER 9
Ik zou jullie bovendien tekort doen als ik hier probeerde te omschrijven wat jullie 
zo bijzonder maakt. Dat we (gekscherend) tot elkaars familie zouden behoren, 
zegt denk ik wel genoeg. Of dat we later als omaatjes samen in een boerderij in 
Overasselt willen wonen. Bedankt dat jullie er altijd voor me zijn en voor zoveel 
gekkigheid en ‘lachen, gieren, brullen’ zorgen. Wellicht is mijn verdediging een 
mooi moment om de naam van onze appgroep (de drie wijzen) in de praktijk te 
laten zien.
Oma, Bert, Wilma, Twan, Myrthe en Maurice, jullie zijn een super schoonfamilie. 
Bedankt voor de nodige afleiding, steun en warmte. Het is fijn om te weten dat 
jullie altijd voor mij klaar zullen staan. Funs, Saskia, Dain, Skye en Levi, met jullie 
valt er altijd wat te beleven. Ik kijk altijd met veel plezier uit naar onze gezamenlijke 
spelletjesavonden of logeerpartijen: gegarandeerd een dolle pret. Funs, je werkte 
maanden aan een inscape-kist voor ons, dat laat wel zien hoeveel je voor ons over 
hebt. Dat is geheel wederzijds. Hanny, René, Lasse, Sverre en Olle, bedankt voor 
de gezellige drukte. Wat is het fijn om toch wat familie dicht in de buurt te hebben 
(vooral handig voor onverwachte en ongeplande bezoekjes). Het wordt tijd dat de 
verjaardagsuitstapjes weer hervat kunnen worden! Lou, dankzij jou voel ik me nog 
steeds af en toe een student. Onze eeuwige strijd om ergens beter in te zijn dan 
de ander, zorgt gelukkig nog steeds voor hilarische momenten. Bedankt voor de 
bijzondere band die we hebben.
Lieve Peter en José, dankzij jullie sta ik straks mijn proefschrift te verdedigen. Jullie 
hebben me bijgebracht om ergens voor te gaan als je je doel wil bereiken. Maar 
belangrijker nog: jullie hebben me geleerd om volop van het leven te genieten. Dat 
doe ik iedere dag. Ik realiseer me nu pas hoe kostbaar dat is. Bedankt!
Lieve Luc, wat heb jij dit hele traject vaak vervloekt. Ik durfde soms bijna niet te 
zeggen tot hoe laat ik de avond ervoor had doorgewerkt. Ik weet dan ook niet wie 
van ons twee blijer is dat dit bijna is afgerond. Toch was daar die onvoorwaardelijke 
steun, vooral de laatste maanden. Ik zal weer meer tijd krijgen voor alles wat we 
zo graag samen doen. Voorlopig geen nachtelijke werksessies meer. Bedankt dat 
je altijd aan mijn zijde staat. Jij laat me ervaren wat echte liefde is. En wat gelukkig 
zijn betekent. 
Lieve, kleine Alex, je hebt nog geen flauw benul van dit alles. Toch was jij de 
afgelopen maanden natuurlijk de leukste afleiding. Bedankt dat jij me iedere dag 
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